Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Peiman Hematti MD

Peiman Hematti MD profile photo picture

Professor

Institution: Medical College of Wisconsin
Department: Medicine
Division: Hematology and Oncology - Medicine
Program: Bone Marrow Transplant

image of /images/ORCIDiD_icon16x16.png   https://orcid.org/0000-0001-5836-4497

Member of the Cancer Center


I am willing to collaborate on research projects.
I am willing to mentor a junior faculty member.

View Curriculum Vitae

Research Areas of Interest

  • Cell- and Tissue-Based Therapy
  • Graft vs Host Disease
  • Hematopoietic Stem Cell Transplantation
  • Hematopoietic Stem Cells
  • Macrophages
  • Stem Cell Transplantation

    • Research Experience

  • Bone Marrow Cells
  • Bone Marrow Transplantation
  • Cell- and Tissue-Based Therapy
  • Clinical Trials, Phase I as Topic
  • Coculture Techniques
  • Exosomes
  • Extracellular Vesicles
  • Fibroblasts
  • Graft vs Host Disease
  • Hematopoiesis
  • Hematopoietic Stem Cell Mobilization
  • Hematopoietic Stem Cell Transplantation
  • Hematopoietic Stem Cells
  • Immune Tolerance
  • Macrophages
  • Multiple Myeloma
  • Peripheral Blood Stem Cells
  • Primates
  • Stem Cell Transplantation
  • Stem Cells
  • Stromal Cells
  • Transplantation, Autologous
  • Transplantation, Haploidentical
  • Tumor Microenvironment

    • Clinical Expertise

  • Bone Marrow Transplantation
  • Cell- and Tissue-Based Therapy
  • Graft vs Host Disease
  • Hematopoietic Stem Cell Mobilization
  • Hematopoietic Stem Cell Transplantation
  • Mesenchymal Stem Cell Transplantation
  • Peripheral Blood Stem Cell Transplantation
  • Stem Cell Transplantation
  • Transplantation, Autologous
  • Whole-Body Irradiation

    • Publications (230)

  • Large-scale bioreactor production of extracellular vesicles from mesenchymal stromal cells for treatment of acute radiation syndrome (Kink JA, Bellio MA, Forsberg MH, Lobo A, Thickens AS, Lewis BM, Ong IM, Khan A, Capitini CM, Hematti P) Stem Cell Research and Therapy December 2024;15(1) SCOPUS ID: 2-s2.0-85187518243 12/01/2024    
  • Outcomes with allogeneic hematopoietic stem cell transplantation in TP53-mutated myelodysplastic syndrome: A systematic review and meta-analysis. (Shahzad M, Iqbal Q, Tariq E, Ammad-Ud-Din M, Butt A, Mushtaq AH, Ali F, Chaudhary SG, Anwar I, Gonzalez-Lugo JD, Abdelhakim H, Ahmed N, Hematti P, Singh AK, McGuirk JP, Mushtaq MU) Crit Rev Oncol Hematol 2024 Apr;196:104310 PMID: 38423375 SCOPUS ID: 2-s2.0-85187575279 03/01/2024    
  • Intensive care risk and long-term outcomes in pediatric allogeneic hematopoietic cell transplant recipients. (Zinter MS, Brazauskas R, Strom J, Chen S, Bo-Subait S, Sharma A, Beitinjaneh A, Dimitrova D, Guilcher G, Preussler J, Myers K, Bhatt NS, Ringden O, Hematti P, Hayashi RJ, Patel S, De Oliveira SN, Rotz S, Badawy SM, Nishihori T, Buchbinder D, Hamilton B, Savani B, Schoemans H, Sorror M, Winestone L, Duncan C, Phelan R, Dvorak CC) Blood Adv 2024 Feb 27;8(4):1002-1017 PMID: 38127268 PMCID: PMC10879681 SCOPUS ID: 2-s2.0-85187724652 12/21/2023       1 Citation
  • PD1+TIGIT+2B4+KLRG1+ Cells Might Underlie T Cell Dysfunction in Patients Treated with BCMA-Directed Chimeric Antigen Receptor T Cell Therapy. (Mishra AK, Schmidt TM, Martell EB, Chen AS, Dogru RE, Hematti P, Callander NS) Transplant Cell Ther 2024 Feb;30(2):191-202 PMID: 37967650 SCOPUS ID: 2-s2.0-85180592139 11/16/2023       1 Citation
  • Modulating Mesenchymal Stromal Cell Microenvironment Alters Exosome RNA Content and Ligament Healing Capacity. (Chamberlain C, Prabahar A, Kink J, Mueller E, Li Y, Yopp S, Capitini C, William M, Hematti P, Vanderby R, Jiang P) bioRxiv 2023 Nov 19 PMID: 37961625 PMCID: PMC10634732 11/14/2023    
  • Severity of Chronic Graft-versus-Host Disease and Late Effects Following Allogeneic Hematopoietic Cell Transplantation for Adults with Hematologic Malignancy. (Lee CJ, Wang T, Chen K, Arora M, Brazauskas R, Spellman SR, Kitko C, MacMillan ML, Pidala JA, Badawy SM, Bhatt N, Bhatt VR, DeFilipp Z, Diaz MA, Farhadfar N, Gadalla S, Hashmi S, Hematti P, Hossain NM, Inamoto Y, Lekakis LJ, Sharma A, Solomon S, Lee SJ, Couriel DR) Transplant Cell Ther 2024 Jan;30(1):97.e1-97.e14 PMID: 37844687 PMCID: PMC10842798 SCOPUS ID: 2-s2.0-85176587436 10/17/2023       1 Citation
  • Incidence and Impact of Fungal Infections in Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis and Haploidentical Hematopoietic Cell Transplantation: A Center for International Blood and Marrow Transplant Research Analysis. (Papanicolaou GA, Chen M, He N, Martens MJ, Kim S, Batista MV, Bhatt NS, Hematti P, Hill JA, Liu H, Nathan S, Seftel MD, Sharma A, Waller EK, Wingard JR, Young JH, Dandoy CE, Perales MA, Chemaly RF, Riches M, Ustun C) Transplant Cell Ther 2024 Jan;30(1):114.e1-114.e16 PMID: 37775070 PMCID: PMC10872466 SCOPUS ID: 2-s2.0-85176212764 09/30/2023       1 Citation
  • Correction: Psychological and physical function in allogeneic hematopoietic cell transplant survivors with chronic graft-versus-host disease. (Hansen JL, Juckett MB, Foster MA, Rumble ME, Morris KE, Hematti P, Costanzo ES) J Cancer Surviv 2023 Aug 23 PMID: 37610480 SCOPUS ID: 2-s2.0-85168608081 08/23/2023    
  • Effects of Atrazine exposure on human bone marrow-derived mesenchymal stromal cells assessed by combinatorial assay matrix. (Uwazie CC, Pirlot BM, Faircloth TU, Patel M, Parr RN, Zastre HM, Hematti P, Moll G, Rajan D, Chinnadurai R) Front Immunol 2023;14:1214098 PMID: 37588595 PMCID: PMC10426140 SCOPUS ID: 2-s2.0-85168089096 08/17/2023       1 Citation
  • TCR-α/β and CD19 depleted stem cell grafts from haploidentical donors for allogeneic transplantation in patients with relapsed lymphoma: a single-center experience. (Kenkre VP, Bradley K, Milton A, Burkholder JK, Grindle K, McMannes J, Kim K, Callander N, Juckett M, Longo W, Hematti P) Leuk Lymphoma 2023;64(11):1875-1879 PMID: 37585704 SCOPUS ID: 2-s2.0-85167669442 08/16/2023    
  • Critical Illness Risk and Long-Term Outcomes Following Intensive Care in Pediatric Hematopoietic Cell Transplant Recipients. (Zinter MS, Brazauskas R, Strom J, Chen S, Bo-Subait S, Sharma A, Beitinjaneh A, Dimitrova D, Guilcher G, Preussler J, Myers K, Bhatt NS, Ringden O, Hematti P, Hayashi RJ, Patel S, De Oliveira SN, Rotz S, Badawy SM, Nishihori T, Buchbinder D, Hamilton B, Savani B, Schoemans H, Sorror M, Winestone L, Duncan C, Phelan R, Dvorak CC) medRxiv 2023 Aug 05 PMID: 37577706 PMCID: PMC10418579 08/14/2023    
  • Randomized Phase II Trial of Dendritic Cell/Myeloma Fusion Vaccine with Lenalidomide Maintenance after Upfront Autologous Hematopoietic Cell Transplantation for Multiple Myeloma: BMT CTN 1401. (Chung DJ, Shah N, Wu J, Logan B, Bisharat L, Callander N, Cheloni G, Anderson K, Chodon T, Dhakal B, Devine S, Somaiya Dutt P, Efebera Y, Geller N, Ghiasuddin H, Hematti P, Holmberg L, Howard A, Johnson B, Karagkouni D, Lazarus HM, Malek E, McCarthy P, McKenna D, Mendizabal A, Nooka A, Munshi N, O'Donnell L, Rapoport AP, Reese J, Rosenblatt J, Soiffer R, Stroopinsky D, Uhl L, Vlachos IS, Waller EK, Young JW, Pasquini MC, Avigan D) Clin Cancer Res 2023 Dec 01;29(23):4784-4796 PMID: 37463058 PMCID: PMC10690096 SCOPUS ID: 2-s2.0-85178651085 07/18/2023       3 Citations
  • Helical TomoTherapy Total Lymphoid Irradiation and Hematopoietic Cell Transplantation for Kidney Transplant Tolerance in Rhesus Macaques. (Kaufman DB, Forrest LJ, Fechner J, Post J, Coonen J, Haynes LD, Haynes WJ, Christensen N, Zhong W, Little CJ, D'Alessandro A, Fernandez L, Brunner K, Jensen K, Burlingham WJ, Hematti P, Strober S) Transpl Int 2023;36:11279 PMID: 37426429 PMCID: PMC10324513 SCOPUS ID: 2-s2.0-85164146100 07/10/2023       1 Citation
  • Inflammatory cytokines and depression symptoms following hematopoietic cell transplantation. (Nelson AM, Erdmann AA, Coe CL, Juckett MB, Morris K, Knight JM, Hematti P, Costanzo ES) Brain Behav Immun 2023 Aug;112:11-17 PMID: 37236325 PMCID: PMC10524437 SCOPUS ID: 2-s2.0-85160562513 05/27/2023       1 Citation
  • Extracellular-Vesicle-Based Therapeutics in Neuro-Ophthalmic Disorders. (Massoumi H, Amin S, Soleimani M, Momenaei B, Ashraf MJ, Guaiquil VH, Hematti P, Rosenblatt MI, Djalilian AR, Jalilian E) Int J Mol Sci 2023 May 19;24(10) PMID: 37240353 PMCID: PMC10219002 SCOPUS ID: 2-s2.0-85160377092 05/27/2023       8 Citations
  • Contrariety of Human Bone Marrow Mesenchymal Stromal Cell Functionality in Modulating Circulatory Myeloid and Plasmacytoid Dendritic Cell Subsets. (Uwazie CC, Faircloth TU, Parr RN, Reddy YU, Hematti P, Rajan D, Chinnadurai R) Biology (Basel) 2023 May 16;12(5) PMID: 37237538 PMCID: PMC10215629 SCOPUS ID: 2-s2.0-85160307262 05/27/2023       1 Citation
  • Outcomes with chimeric antigen receptor t-cell therapy in relapsed or refractory acute myeloid leukemia: a systematic review and meta-analysis. (Shahzad M, Nguyen A, Hussain A, Ammad-Ud-Din M, Faisal MS, Tariq E, Ali F, Butt A, Anwar I, Chaudhary SG, Lutfi F, Ahmed N, Singh AK, Hematti P, McGuirk JP, Mushtaq MU) Front Immunol 2023;14:1152457 PMID: 37168849 PMCID: PMC10164930 SCOPUS ID: 2-s2.0-85158169518 05/12/2023       6 Citations
  • Exosomes, MDSCs and Tregs: A new frontier for GVHD prevention and treatment. (Hess NJ, Kink JA, Hematti P) Front Immunol 2023;14:1143381 PMID: 37063900 PMCID: PMC10090348 SCOPUS ID: 2-s2.0-85152619611 04/18/2023       2 Citations
  • Inflammatory CD4/CD8 double-positive human T cells arise from reactive CD8 T cells and are sufficient to mediate GVHD pathology. (Hess NJ, Turicek DP, Riendeau J, McIlwain SJ, Contreras Guzman E, Nadiminti K, Hudson A, Callander NS, Skala MC, Gumperz JE, Hematti P, Capitini CM) Sci Adv 2023 Mar 24;9(12):eadf0567 PMID: 36961891 PMCID: PMC10038349 SCOPUS ID: 2-s2.0-85151044773 03/25/2023       6 Citations
  • Ixazomib for Desensitization (IXADES) in Highly Sensitized Kidney Transplant Candidates: A Phase II Clinical Trial. (Wilson N, Reese S, Ptak L, Aziz F, Parajuli S, Jucaud V, Denham S, Mishra A, Cascalho M, Platt JL, Hematti P, Djamali A) Kidney360 2023 Jun 01;4(6):e796-e808 PMID: 36951387 PMCID: PMC10371382 SCOPUS ID: 2-s2.0-85164231862 03/24/2023    
  • Psychological and physical function in allogeneic hematopoietic cell transplant survivors with chronic graft-versus-host disease. (Hansen JL, Juckett MB, Foster MA, Rumble ME, Morris KE, Hematti P, Costanzo ES) J Cancer Surviv 2023 Jun;17(3):646-656 PMID: 36917433 PMCID: PMC10246467 SCOPUS ID: 2-s2.0-85149922471 03/15/2023       1 Citation
  • Outcomes of Tyrosine Kinase Inhibitors Maintenance Therapy with or without Allogeneic Hematopoietic Stem Cell Transplantation in Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia in First Complete Remission: A Systematic Review and Meta-Analysis. (Shahzad M, Hussain A, Tariq E, Anwar I, Faisal MS, Syed L, Karam A, Chaudhary SG, Ahmed N, Bansal R, Khurana S, Singh AK, Byrd KP, Hematti P, Abhyankar SH, McGuirk JP, Mushtaq MU) Clin Lymphoma Myeloma Leuk 2023 Mar;23(3):178-187 PMID: 36682989 SCOPUS ID: 2-s2.0-85146611234 01/23/2023       3 Citations
  • TCR-α/β and CD19 depleted stem cell grafts from haploidentical donors for allogeneic transplantation in patients with relapsed lymphoma: a single-center experience (Kenkre VP, Bradley K, Milton A, Burkholder JK, Grindle K, McMannes J, Kim KM, Callander N, Juckett M, Longo W, Hematti P) Leukemia and Lymphoma 2023;64(11):1875-1879 SCOPUS ID: 2-s2.0-85167669442 01/01/2023    
  • Correction: Psychological and physical function in allogeneic hematopoietic cell transplant survivors with chronic graft-versus-host disease (Journal of Cancer Survivorship, (2023), 17, 3, (646-656), 10.1007/s11764-023-01354-9) (Hansen JL, Juckett MB, Foster MA, Rumble ME, Morris KE, Hematti P, Costanzo ES) Journal of Cancer Survivorship 2023 SCOPUS ID: 2-s2.0-85168608081 01/01/2023    
  • The incidence and impact of clostridioides difficile infection on transplant outcomes in acute leukemia and MDS after allogeneic hematopoietic cell transplant-a CIBMTR study. (Ramanathan M, Kim S, He N, Chen M, Hematti P, Abid MB, Rotz SJ, Williams KM, Lazarus HM, Wirk B, Yin DE, Kanakry CG, Perales MA, Chemaly RF, Dandoy CE, Riches M, Ustun C) Bone Marrow Transplant 2023 Apr;58(4):360-366 PMID: 36543999 PMCID: PMC10079570 SCOPUS ID: 2-s2.0-85144532838 12/22/2022       5 Citations
  • Use of endpoints in phase III randomized controlled trials for acute myeloid leukemia over the last 15 years: a systematic review. (Shahzad M, Chaudhary SG, Tariq E, Mushtaq AH, Anwar I, Ahmed N, Bansal R, Lutfi F, Balusu R, Abdelhakim H, Yacoub A, Hematti P, Singh AK, McGuirk JP, Mushtaq MU) Leuk Lymphoma 2023 Feb;64(2):273-282 PMID: 36282773 SCOPUS ID: 2-s2.0-85141149935 10/26/2022       1 Citation
  • Outcomes with mismatched unrelated donor allogeneic hematopoietic stem cell transplantation in adults: A systematic review and meta-analysis. (Mushtaq MU, Shahzad M, Tariq E, Iqbal Q, Chaudhary SG, Zafar MU, Anwar I, Ahmed N, Bansal R, Singh AK, Abhyankar SH, Callander NS, Hematti P, McGuirk JP) Front Oncol 2022;12:1005042 PMID: 36276084 PMCID: PMC9583270 SCOPUS ID: 2-s2.0-85140257571 10/25/2022       6 Citations
  • Impact of natural killer cells on outcomes after allogeneic hematopoietic stem cell transplantation: A systematic review and meta-analysis. (Mushtaq MU, Shahzad M, Shah AY, Chaudhary SG, Zafar MU, Anwar I, Neupane K, Khalid A, Ahmed N, Bansal R, Balusu R, Singh AK, Abhyankar SH, Callander NS, Hematti P, McGuirk JP) Front Immunol 2022;13:1005031 PMID: 36263054 PMCID: PMC9574024 SCOPUS ID: 2-s2.0-85139999763 10/21/2022       1 Citation
  • Perturbation of the gut microbiome and association with outcomes following autologous stem cell transplantation in patients with multiple myeloma. (D'Angelo C, Sudakaran S, Asimakopoulos F, Hematti P, El-Gamal D, Safdar N, Callander N) Leuk Lymphoma 2023 Jan;64(1):87-97 PMID: 36218226 PMCID: PMC9905274 SCOPUS ID: 2-s2.0-85139755097 10/12/2022       7 Citations
  • Outcomes with allogeneic hematopoietic stem cell transplantation in TP53-mutated acute myeloid leukemia: a systematic review and meta-analysis. (Shahzad M, Tariq E, Chaudhary SG, Anwar I, Iqbal Q, Fatima H, Abdelhakim H, Ahmed N, Balusu R, Hematti P, Singh AK, McGuirk JP, Mushtaq MU) Leuk Lymphoma 2022 Dec;63(14):3409-3417 PMID: 36107118 SCOPUS ID: 2-s2.0-85138195603 09/16/2022       10 Citations
  • Integrated analysis of the tumor microenvironment using a reconfigurable microfluidic cell culture platform. (Sethakorn N, Heninger E, Breneman MT, Recchia E, Ding AB, Jarrard DF, Hematti P, Beebe DJ, Kosoff D) FASEB J 2022 Oct;36(10):e22540 PMID: 36083096 PMCID: PMC9476232 SCOPUS ID: 2-s2.0-85138126695 09/10/2022       2 Citations
  • Conglomeration of T- and B-Cell Matrix Responses Determines the Potency of Human Bone Marrow Mesenchymal Stromal Cells. (Porter AP, Pirlot BM, Dyer K, Uwazie CC, Nguyen J, Turner C, Rajan D, Hematti P, Chinnadurai R) Stem Cells 2022 Dec 31;40(12):1134-1148 PMID: 36056823 SCOPUS ID: 2-s2.0-85145424751 09/04/2022       5 Citations
  • Bone marrow mesenchymal stromal cells in a 3D system produce higher concentration of extracellular vesicles (EVs) with increased complexity and enhanced neuronal growth properties. (Jalilian E, Massoumi H, Bigit B, Amin S, Katz EA, Guaiquil VH, Anwar KN, Hematti P, Rosenblatt MI, Djalilian AR) Stem Cell Res Ther 2022 Aug 19;13(1):425 PMID: 35986305 PMCID: PMC9389821 SCOPUS ID: 2-s2.0-85136531980 08/20/2022       23 Citations
  • Chemokine Assay Matrix Defines the Potency of Human Bone Marrow Mesenchymal Stromal Cells. (Lipat AJ, Cottle C, Pirlot BM, Mitchell J, Pando B, Helmly B, Kosko J, Rajan D, Hematti P, Chinnadurai R) Stem Cells Transl Med 2022 Sep 21;11(9):971-986 PMID: 35881077 PMCID: PMC9492268 SCOPUS ID: 2-s2.0-85138458373 07/27/2022       11 Citations
  • Association of Chronic Graft-versus-Host Disease with Late Effects following Allogeneic Hematopoietic Cell Transplantation for Children with Hematologic Malignancy. (Lee CJ, Wang T, Chen K, Arora M, Brazauskas R, Spellman SR, Kitko C, MacMillan ML, Pidala JA, Auletta JJ, Badawy SM, Bhatt N, Bhatt VR, Cahn JY, DeFilipp Z, Diaz MA, Farhadfar N, Gadalla S, Gale RP, Hashem H, Hashmi S, Hematti P, Hong S, Hossain NM, Inamoto Y, Lekakis LJ, Modi D, Patel S, Sharma A, Solomon S, Couriel DR) Transplant Cell Ther 2022 Oct;28(10):712.e1-712.e8 PMID: 35863740 PMCID: PMC9547959 SCOPUS ID: 2-s2.0-85136151813 07/22/2022       3 Citations
  • Characteristics of Graft-Versus-Host Disease (GvHD) After Post-Transplantation Cyclophosphamide Versus Conventional GvHD Prophylaxis. (Saliba RM, Alousi AM, Pidala J, Arora M, Spellman SR, Hemmer MT, Wang T, Abboud C, Ahmed S, Antin JH, Beitinjaneh A, Buchbinder D, Byrne M, Cahn JY, Choe H, Hanna R, Hematti P, Kamble RT, Kitko CL, Laughlin M, Lekakis L, MacMillan ML, Martino R, Mehta PA, Nishihori T, Patel SS, Perales MA, Rangarajan HG, Ringdén O, Rosenthal J, Savani BN, Schultz KR, Seo S, Teshima T, van der Poel M, Verdonck LF, Weisdorf D, Wirk B, Yared JA, Schriber J, Champlin RE, Ciurea SO) Transplant Cell Ther 2022 Oct;28(10):681-693 PMID: 35853610 PMCID: PMC10141544 SCOPUS ID: 2-s2.0-85137041583 07/20/2022       11 Citations
  • Allogeneic MHC-matched T-cell receptor α/β-depleted bone marrow transplants in SHIV-infected, ART-suppressed Mauritian cynomolgus macaques. (Weinfurter JT, D'Souza SS, Matschke LM, Bennett S, Kelnhofer-Millevolte LE, Suknuntha K, Kumar A, Coonen J, Capitini CM, Hematti P, Golos TG, Slukvin II, Reynolds MR) Sci Rep 2022 Jul 19;12(1):12345 PMID: 35853970 PMCID: PMC9296477 SCOPUS ID: 2-s2.0-85134413904 07/20/2022    
  • Top 100 Cited Articles on Clinical Hematopoietic Stem Cell Transplantation: A Bibliometric Analysis. (Shahzad M, Chaudhary SG, Anwar I, Arslan M, Naseem Z, Fatima NT, Abbas S, Ali T, Siddiqui RS, Hematti P, Abhyankar SH, McGuirk JP, Mushtaq MU) Front Med (Lausanne) 2022;9:872692 PMID: 35733859 PMCID: PMC9208296 SCOPUS ID: 2-s2.0-85133462180 06/24/2022       1 Citation
  • Outcomes after venetoclax with hypomethylating agents in myelodysplastic syndromes: a systematic review and meta-analysis. (Khanam R, Shahzad M, Chaudhary SG, Ali F, Shah Z, Pachika PS, Ahmed Z, Chattaraj A, Masood A, Ahmed N, Bansal R, Balusu R, Shune L, Anwar F, Hematti P, McGuirk JP, Yacoub A, Mushtaq MU) Leuk Lymphoma 2022 Nov;63(11):2671-2678 PMID: 35687838 SCOPUS ID: 2-s2.0-85131691532 06/11/2022    
  • A biobehavioral intervention to enhance recovery following hematopoietic cell transplantation: Protocol for a feasibility and acceptability randomized control trial. (Kirvin-Quamme A, Rumble ME, Cadmus-Bertram L, Juckett MB, Rathouz PJ, Schell G, Callander NS, Hematti P, Costanzo ES) Contemp Clin Trials Commun 2022 Aug;28:100938 PMID: 35664502 PMCID: PMC9160488 SCOPUS ID: 2-s2.0-85131543124 06/07/2022       1 Citation
  • A Hyaluronan and Proteoglycan Link Protein 1 Matrikine: Role of Matrix Metalloproteinase 2 in Multiple Myeloma NF-κB Activation and Drug Resistance. (Mark C, Warrick J, Callander NS, Hematti P, Miyamoto S) Mol Cancer Res 2022 Sep 02;20(9):1456-1466 PMID: 35604822 PMCID: PMC9444915 SCOPUS ID: 2-s2.0-85137138707 05/24/2022       4 Citations
  • Male-specific late effects in adult hematopoietic cell transplantation recipients: a systematic review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and Transplant Complications Working Party of the European Society of Blood and Marrow Transplantation. (Phelan R, Im A, Hunter RL, Inamoto Y, Lupo-Stanghellini MT, Rovo A, Badawy SM, Burns L, Eissa H, Murthy HS, Prasad P, Sharma A, Suelzer E, Agrawal V, Aljurf M, Baker K, Basak GW, Buchbinder D, DeFilipp Z, Grkovic LD, Dias A, Einsele H, Eisenberg ML, Epperla N, Farhadfar N, Flatau A, Gale RP, Greinix H, Hamilton BK, Hashmi S, Hematti P, Jamani K, Maharaj D, Murray J, Naik S, Nathan S, Pavletic S, Peric Z, Pulanic D, Ross R, Salonia A, Sanchez-Ortega I, Savani BN, Schechter T, Shah AJ, Smith SM, Snowden JA, Steinberg A, Tremblay D, Vij SC, Walker L, Wolff D, Yared JA, Schoemans H, Tichelli A) Bone Marrow Transplant 2022 Jul;57(7):1150-1163 PMID: 35523848 PMCID: PMC10316716 SCOPUS ID: 2-s2.0-85129492511 05/07/2022       4 Citations
  • Pro-angiogenic Potential of Mesenchymal Stromal Cells Regulated by Matrix Stiffness and Anisotropy Mimicking Right Ventricles. (Nguyen-Truong M, Kim S, Doherty C, Frederes M, LeBar K, Ghosh S, Hematti P, Chinnadurai R, Wagner WR, Wang Z) Biomacromolecules 2022 Jun 13;23(6):2353-2361 PMID: 35502841 SCOPUS ID: 2-s2.0-85130048923 05/04/2022       1 Citation
  • Does recipient body mass index inform donor selection for allogeneic haematopoietic cell transplantation? (Abou-Ismail MY, Fraser R, Allbee-Johnson M, Metheny L 3rd, Ravi G, Ahn KW, Bhatt NS, Lazarus HM, de Lima M, El Jurdy N, Hematti P, Beitinjaneh AM, Nishihori T, Badawy SM, Sharma A, Pasquini MC, Savani BN, Sorror ML, Stadtmauer EA, Chhabra S) Br J Haematol 2022 May;197(3):326-338 PMID: 35286719 PMCID: PMC9675037 SCOPUS ID: 2-s2.0-85126235994 03/15/2022       1 Citation
  • Gender disparities in the National Institutes of Health funding for hematologic malignancies and cellular therapies. (Siddiqui RS, Chaudhary SG, Shahzad M, Anwar I, Hussain A, Ahmed N, Abhyankar SH, Shune L, Hematti P, Male H, Khosa F, Lin T, McGuirk JP, Callander NS, Mushtaq MU) Leuk Lymphoma 2022 Jul;63(7):1708-1713 PMID: 35142581 SCOPUS ID: 2-s2.0-85125151936 02/11/2022       4 Citations
  • Impact of COVID-19 in hematopoietic stem cell transplant recipients: A systematic review and meta-analysis. (Shahzad M, Chaudhary SG, Zafar MU, Hassan MA, Hussain A, Ali F, Anwar I, Ahmed M, Ahmed N, Khurana S, Rauf MA, Anwar F, Hematti P, Callander NS, Abhyankar SH, McGuirk JP, Mushtaq MU) Transpl Infect Dis 2022 Apr;24(2):e13792 PMID: 35030267 SCOPUS ID: 2-s2.0-85123552804 01/15/2022       25 Citations
  • Hepatocellular Carcinoma Cells Are Protected From Immunolysis by Mesenchymal Stromal Cells Through Indoleamine 2,3 Dioxygenase. (Chinnadurai R, Porter AP, Patel M, Lipat AJ, Forsberg MH, Rajan D, Hematti P, Capitini CM, Bruker C) Front Cell Dev Biol 2021;9:715905 PMID: 34869307 PMCID: PMC8633446 SCOPUS ID: 2-s2.0-85120401203 12/07/2021       5 Citations
  • Male-Specific Late Effects in Adult Hematopoietic Cell Transplantation Recipients: A Systematic Review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and Transplant Complications Working Party of the European Society of Blood and Marrow Transplantation. (Phelan R, Im A, Hunter RL, Inamoto Y, Lupo-Stanghellini MT, Rovo A, Badawy SM, Burns L, Eissa H, Murthy HS, Prasad P, Sharma A, Suelzer E, Agrawal V, Aljurf M, Baker K, Basak GW, Buchbinder D, DeFilipp Z, Grkovic LD, Dias A, Einsele H, Eisenberg ML, Epperla N, Farhadfar N, Flatau A, Gale RP, Greinix H, Hamilton BK, Hashmi S, Hematti P, Jamani K, Maharaj D, Murray J, Naik S, Nathan S, Pavletic S, Peric Z, Pulanic D, Ross R, Salonia A, Sanchez-Ortega I, Savani BN, Schechter T, Shah AJ, Smith SM, Snowden JA, Steinberg A, Tremblay D, Vij SC, Walker L, Wolff D, Yared JA, Schoemans H, Tichelli A) Transplant Cell Ther 2022 Jun;28(6):335.e1-335.e17 PMID: 34757220 PMCID: PMC9050968 SCOPUS ID: 2-s2.0-85127295019 11/11/2021       5 Citations
  • Allogeneic transplant and CAR-T therapy after autologous transplant failure in DLBCL: a noncomparative cohort analysis. (Hamadani M, Gopal AK, Pasquini M, Kim S, Qiu X, Ahmed S, Lazaryan A, Bhatt VR, Daly A, Lulla P, Ciurea S, Gauthier J, Agrawal V, Grover NS, Lekakis L, Modi D, Dahi PB, Herr MM, Johnson PC, Hashmi H, Hematti P, Locke FL) Blood Adv 2022 Jan 25;6(2):486-494 PMID: 34673903 PMCID: PMC8791562 SCOPUS ID: 2-s2.0-85123544420 10/22/2021       24 Citations
  • Post-Transplantation Cyclophosphamide Is Associated with an Increase in Non-Cytomegalovirus Herpesvirus Infections in Patients with Acute Leukemia and Myelodysplastic Syndrome. (Singh A, Dandoy CE, Chen M, Kim S, Mulroney CM, Kharfan-Dabaja MA, Ganguly S, Maziarz RT, Kanakry CG, Kanakry JA, Patel SS, Hill JA, De Oliveir S, Taplitz R, Hematti P, Lazarus HM, Abid MB, Goldsmith SR, Romee R, Komanduri KV, Badawy SM, Friend BD, Beitinjaneh A, Politikos I, Perales MA, Riches M) Transplant Cell Ther 2022 Jan;28(1):48.e1-48.e10 PMID: 34587551 PMCID: PMC9717499 SCOPUS ID: 2-s2.0-85118874792 09/30/2021       20 Citations
  • Autologous transplant vs chimeric antigen receptor T-cell therapy for relapsed DLBCL in partial remission. (Shadman M, Pasquini M, Ahn KW, Chen Y, Turtle CJ, Hematti P, Cohen JB, Khimani F, Ganguly S, Merryman RW, Yared JA, Locke FL, Ahmed N, Munshi PN, Beitinjaneh A, Reagan PM, Herrera AF, Sauter CS, Kharfan-Dabaja MA, Hamadani M) Blood 2022 Mar 03;139(9):1330-1339 PMID: 34570879 PMCID: PMC8900276 SCOPUS ID: 2-s2.0-85125439632 09/28/2021       49 Citations
  • Planned Granulocyte Colony-Stimulating Factor Adversely Impacts Survival after Allogeneic Hematopoietic Cell Transplantation Performed with Thymoglobulin for Myeloid Malignancy. (Orfali N, Zhang MJ, Allbee-Johnson M, Boelens JJ, Artz AS, Brunstein CG, McNiece IK, Milano F, Abid MB, Chee L, Diaz MA, Grunwald MR, Hematti P, Hsu J, Lazarus HM, Munshi PN, Prestidge T, Ringden O, Rizzieri D, Riches ML, Seo S, Solh M, Solomon S, Szwajcer D, Yared J, van Besien K, Eapen M) Transplant Cell Ther 2021 Dec;27(12):993.e1-993.e8 PMID: 34507002 PMCID: PMC8671234 SCOPUS ID: 2-s2.0-85120751167 09/11/2021       4 Citations
  • Exosomes from primed MSCs can educate monocytes as a cellular therapy for hematopoietic acute radiation syndrome. (Forsberg MH, Kink JA, Thickens AS, Lewis BM, Childs CJ, Hematti P, Capitini CM) Stem Cell Res Ther 2021 Aug 18;12(1):459 PMID: 34407878 PMCID: PMC8371870 SCOPUS ID: 2-s2.0-85112782090 08/20/2021       6 Citations
  • Tomotherapy Applied Total Lymphoid Irradiation and Allogeneic Hematopoietic Cell Transplantation Generates Mixed Chimerism in the Rhesus Macaque Model. (Forrest L, Fechner J, Post J, Van Asselt N, Kvasnica K, Haynes LD, Coonen J, Brunner K, Haynes WJ, Little C, Burlingham WJ, Hematti P, Strober S, Kaufman DB) Radiat Res 2021 Dec 01;196(6):623-632 PMID: 34388816 PMCID: PMC8826536 SCOPUS ID: 2-s2.0-85121108466 08/14/2021       5 Citations
  • Preclinical Evaluation of the Safety and Efficacy of Cryopreserved Bone Marrow Mesenchymal Stromal Cells for Corneal Repair. (Putra I, Shen X, Anwar KN, Rabiee B, Samaeekia R, Almazyad E, Giri P, Jabbehdari S, Hayat MR, Elhusseiny AM, Ghassemi M, Mahmud N, Edward DP, Joslin CE, Rosenblatt MI, Dana R, Eslani M, Hematti P, Djalilian AR) Transl Vis Sci Technol 2021 Aug 12;10(10):3 PMID: 34383879 PMCID: PMC8362636 SCOPUS ID: 2-s2.0-85112771364 08/13/2021       11 Citations
  • Outcomes with CD34-Selected Stem Cell Boost for Poor Graft Function after Allogeneic Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis. (Shahzad M, Siddiqui RS, Anwar I, Chaudhary SG, Ali T, Naseem M, Ahmed TF, Ahmed Z, Khurana S, Ahmed N, Balusu R, Singh AK, Hematti P, Callander NS, Abhyankar SH, McGuirk JP, Mushtaq MU) Transplant Cell Ther 2021 Oct;27(10):877.e1-877.e8 PMID: 34284148 SCOPUS ID: 2-s2.0-85112513565 07/21/2021       17 Citations
  • Current status of myocardial restoration via the paracrine function of mesenchymal stromal cells. (Nguyen-Truong M, Hematti P, Wang Z) Am J Physiol Heart Circ Physiol 2021 Jul 01;321(1):H112-H127 PMID: 34085844 SCOPUS ID: 2-s2.0-85109117894 06/05/2021       5 Citations
  • Shorter Interdonation Interval Contributes to Lower Cell Counts in Subsequent Stem Cell Donations. (Panch SR, Logan B, Sees JA, Bo-Subait S, Savani B, Shah NN, Hsu JW, Switzer G, Lazarus HM, Anderlini P, Hematti P, Confer D, Pulsipher MA, Shaw BE, Stroncek DF) Transplant Cell Ther 2021 Jun;27(6):503.e1-503.e8 PMID: 33823169 PMCID: PMC8217152 SCOPUS ID: 2-s2.0-85103924669 04/07/2021       1 Citation
  • Impact of Pretransplantation Renal Dysfunction on Outcomes after Allogeneic Hematopoietic Cell Transplantation. (Farhadfar N, Dias A, Wang T, Fretham C, Chhabra S, Murthy HS, Broglie L, D'Souza A, Gadalla SM, Gale RP, Hashmi S, Al-Homsi AS, Hildebrandt GC, Hematti P, Rizzieri D, Chee L, Lazarus HM, Bredeson C, Jaimes EA, Beitinjaneh A, Bashey A, Prestidge T, Krem MM, Marks DI, Benoit S, Yared JA, Nishihori T, Olsson RF, Freytes CO, Stadtmauer E, Savani BN, Sorror ML, Ganguly S, Wingard JR, Pasquini M) Transplant Cell Ther 2021 May;27(5):410-422 PMID: 33775617 PMCID: PMC8168834 SCOPUS ID: 2-s2.0-85103656481 03/30/2021       11 Citations
  • Sleep Disruption, Fatigue, and Depression as Predictors of 6-Year Clinical Outcomes Following Allogeneic Hematopoietic Cell Transplantation. (Rentscher KE, Carroll JE, Juckett MB, Coe CL, Broman AT, Rathouz PJ, Hematti P, Costanzo ES) J Natl Cancer Inst 2021 Oct 01;113(10):1405-1414 PMID: 33693799 PMCID: PMC8633423 SCOPUS ID: 2-s2.0-85110466952 03/12/2021       15 Citations
  • Optimization of oxidative stress for mesenchymal stromal/stem cell engraftment, function and longevity. (Denu RA, Hematti P) Free Radic Biol Med 2021 May 01;167:193-200 PMID: 33677063 SCOPUS ID: 2-s2.0-85102882887 03/08/2021       15 Citations
  • Cardiac fibroblast derived matrix-educated macrophages express VEGF and IL-6, and recruit mesenchymal stromal cells. (Roy S, Spinali K, Schmuck EG, Kink JA, Hematti P, Raval AN) J Immunol Regen Med 2020 Dec;10 PMID: 33564732 PMCID: PMC7869854 02/11/2021    
  • Cultured cardiac fibroblasts and myofibroblasts express Sushi Containing Domain 2 and assemble a unique fibronectin rich matrix. (Schmuck EG, Roy S, Dhillon A, Walker S, Spinali K, Colevas S, Zhou T, Chhabra G, Liu Y, Kader Sagar MA, Childs CJ, Kink JA, Eliceiri KW, Hematti P, Raval AN) Exp Cell Res 2021 Feb 15;399(2):112489 PMID: 33453237 SCOPUS ID: 2-s2.0-85100124352 01/17/2021       4 Citations
  • Sirtuins and stem cell maintenance, proliferation, and differentiation (Denu RA, Hematti P) Sirtuin Biology in Medicine: Targeting New Avenues of Care in Development, Aging, and Disease 1 January 2021:175-190 SCOPUS ID: 2-s2.0-85126397493 01/01/2021       1 Citation
  • Immune profiling of the bone marrow microenvironment in patients with high-risk localized prostate cancer. (Heninger E, Sethakorn N, Kosoff D, Hematti P, Kuczler MD, Pienta KJ, Lang JM) Oncotarget 2020 Nov 17;11(46):4253-4265 PMID: 33245727 PMCID: PMC7679037 SCOPUS ID: 2-s2.0-85097647115 11/28/2020       1 Citation
  • Different Human Immune Lineage Compositions Are Generated in Non-Conditioned NBSGW Mice Depending on HSPC Source. (Hess NJ, Lindner PN, Vazquez J, Grindel S, Hudson AW, Stanic AK, Ikeda A, Hematti P, Gumperz JE) Front Immunol 2020;11:573406 PMID: 33193358 PMCID: PMC7604455 SCOPUS ID: 2-s2.0-85094894828 11/17/2020       18 Citations
  • Transplantation of T-cell receptor α/β-depleted allogeneic bone marrow in nonhuman primates. (D'Souza SS, Bennett S, Kumar A, Kelnhofer LE, Weinfurter J, Suknuntha K, Coonen J, Mejia A, Simmons H, Golos T, Hematti P, Capitini CM, Reynolds MR, Slukvin II) Exp Hematol 2021 Jan;93:44-51 PMID: 33176119 PMCID: PMC7855119 SCOPUS ID: 2-s2.0-85095986934 11/12/2020       2 Citations
  • Real-world evidence of tisagenlecleucel for pediatric acute lymphoblastic leukemia and non-Hodgkin lymphoma. (Pasquini MC, Hu ZH, Curran K, Laetsch T, Locke F, Rouce R, Pulsipher MA, Phillips CL, Keating A, Frigault MJ, Salzberg D, Jaglowski S, Sasine JP, Rosenthal J, Ghosh M, Landsburg D, Margossian S, Martin PL, Kamdar MK, Hematti P, Nikiforow S, Turtle C, Perales MA, Steinert P, Horowitz MM, Moskop A, Pacaud L, Yi L, Chawla R, Bleickardt E, Grupp S) Blood Adv 2020 Nov 10;4(21):5414-5424 PMID: 33147337 PMCID: PMC7656920 SCOPUS ID: 2-s2.0-85096931359 11/05/2020       256 Citations
  • Exosome-educated macrophages and exosomes differentially improve ligament healing. (Chamberlain CS, Kink JA, Wildenauer LA, McCaughey M, Henry K, Spiker AM, Halanski MA, Hematti P, Vanderby R) Stem Cells 2021 Jan;39(1):55-61 PMID: 33141458 PMCID: PMC7821004 SCOPUS ID: 2-s2.0-85096745607 11/04/2020       37 Citations
  • Point of care, bone marrow mononuclear cell therapy in ischemic heart failure patients personalized for cell potency: 12-month feasibility results from CardiAMP heart failure roll-in cohort. (Raval AN, Johnston PV, Duckers HJ, Cook TD, Traverse JH, Altman PA, Dhingra R, Hematti P, Borrello I, Anderson RD, Pepine CJ) Int J Cardiol 2021 Mar 01;326:131-138 PMID: 33091520 SCOPUS ID: 2-s2.0-85095847925 10/23/2020       12 Citations
  • Comparison of salvage chemotherapy regimens and prognostic significance of minimal residual disease in relapsed/refractory acute myeloid leukemia. (Mushtaq MU, Harrington AM, Chaudhary SG, Michaelis LC, Carlson KB, Abedin S, Runass L, Callander NS, Fallon MJ, Juckett M, Hall AC, Hematti P, Mattison RJ, Atallah EL, Guru Murthy GS) Leuk Lymphoma 2021 Jan;62(1):158-166 PMID: 32951486 SCOPUS ID: 2-s2.0-85091139710 09/22/2020       10 Citations
  • Use of MSCs and MSC-educated macrophages to mitigate hematopoietic acute radiation syndrome. (Chinnadurai R, Forsberg MH, Kink JA, Hematti P, Capitini CM) Curr Stem Cell Rep 2020 Sep;6(3):77-85 PMID: 32944493 PMCID: PMC7491866 SCOPUS ID: 2-s2.0-85089089499 09/19/2020       7 Citations
  • Extracellular Vesicles as a Novel Therapeutic Option in Liver Transplantation. (Carlson K, Kink J, Hematti P, Al-Adra DP) Liver Transpl 2020 Nov;26(11):1522-1531 PMID: 32844568 SCOPUS ID: 2-s2.0-85092145200 08/28/2020       18 Citations
  • Mesenchymal Stromal Cells and Exosomes: Progress and Challenges. (Forsberg MH, Kink JA, Hematti P, Capitini CM) Front Cell Dev Biol 2020;8:665 PMID: 32766255 PMCID: PMC7379234 SCOPUS ID: 2-s2.0-85088931858 08/09/2020       69 Citations
  • Reproducible Derivation and Expansion of Corneal Mesenchymal Stromal Cells for Therapeutic Applications. (Jabbehdari S, Yazdanpanah G, Kanu LN, Anwar KN, Shen X, Rabiee B, Putra I, Eslani M, Rosenblatt MI, Hematti P, Djalilian AR) Transl Vis Sci Technol 2020 Feb 21;9(3):26 PMID: 32742756 PMCID: PMC7354855 SCOPUS ID: 2-s2.0-85081257716 08/04/2020       15 Citations
  • Endothelin-1 reduces catabolic activity of human mesenchymal stem/stromal cells during chondro- and osteo-lineage differentiation. (Weishar R, Lee MS, Fontana G, Hematti P, Li WJ) Biochem Biophys Res Commun 2020 Aug 20;529(2):180-185 PMID: 32703408 PMCID: PMC7385289 SCOPUS ID: 2-s2.0-85086567548 07/25/2020       2 Citations
  • Decitabine induction with myeloablative conditioning and allogeneic hematopoietic stem cell transplantation in high-risk patients with myeloid malignancies is associated with a high rate of infectious complications. (D'Angelo CR, Hall A, Woo KM, Kim K, Longo W, Hematti P, Callander N, Kenkre VP, Mattison R, Juckett M) Leuk Res 2020 Sep;96:106419 PMID: 32683127 PMCID: PMC7484445 SCOPUS ID: 2-s2.0-85087860176 07/20/2020       10 Citations
  • Optimal Donor for African Americans with Hematologic Malignancy: HLA-Haploidentical Relative or Umbilical Cord Blood Transplant. (Solomon SR, Martin AS, Zhang MJ, Ballen K, Bashey A, Battiwalla M, Baxter-Lowe LA, Brunstein C, Chhabra S, Perez MAD, Fuchs EJ, Ganguly S, Hardy N, Hematti P, McGuirk J, Peres E, Ringden O, Rizzieri D, Romee R, Solh M, Szwajcer D, van der Poel M, Waller E, William BM, Eapen M) Biol Blood Marrow Transplant 2020 Oct;26(10):1930-1936 PMID: 32649981 PMCID: PMC7530013 SCOPUS ID: 2-s2.0-85089075393 07/11/2020       10 Citations
  • Discovering How Heme Controls Genome Function Through Heme-omics. (Liao R, Zheng Y, Liu X, Zhang Y, Seim G, Tanimura N, Wilson GM, Hematti P, Coon JJ, Fan J, Xu J, Keles S, Bresnick EH) Cell Rep 2020 Jun 30;31(13):107832 PMID: 32610133 PMCID: PMC7382780 SCOPUS ID: 2-s2.0-85086947598 07/02/2020       16 Citations
  • Tocilizumab not associated with increased infection risk after CAR T-cell therapy: implications for COVID-19? (Frigault MJ, Nikiforow S, Mansour MK, Hu ZH, Horowitz MM, Riches ML, Hematti P, Turtle CJ, Zhang MJ, Perales MA, Pasquini MC) Blood 2020 Jul 02;136(1):137-139 PMID: 32457999 PMCID: PMC7332891 SCOPUS ID: 2-s2.0-85087529450 05/28/2020       53 Citations
  • Early T Cell Activation Metrics Predict Graft-versus-Host Disease in a Humanized Mouse Model of Hematopoietic Stem Cell Transplantation. (Hess NJ, Hudson AW, Hematti P, Gumperz JE) J Immunol 2020 Jul 01;205(1):272-281 PMID: 32444392 PMCID: PMC7329317 SCOPUS ID: 2-s2.0-85088373153 05/24/2020       12 Citations
  • Risk Factors for Graft-versus-Host Disease in Haploidentical Hematopoietic Cell Transplantation Using Post-Transplant Cyclophosphamide. (Im A, Rashidi A, Wang T, Hemmer M, MacMillan ML, Pidala J, Jagasia M, Pavletic S, Majhail NS, Weisdorf D, Abdel-Azim H, Agrawal V, Al-Homsi AS, Aljurf M, Askar M, Auletta JJ, Bashey A, Beitinjaneh A, Bhatt VR, Byrne M, Cahn JY, Cairo M, Castillo P, Cerny J, Chhabra S, Choe H, Ciurea S, Daly A, Perez MAD, Farhadfar N, Gadalla SM, Gale R, Ganguly S, Gergis U, Hanna R, Hematti P, Herzig R, Hildebrandt GC, Lad DP, Lee C, Lehmann L, Lekakis L, Kamble RT, Kharfan-Dabaja MA, Khandelwal P, Martino R, Murthy HS, Nishihori T, O'Brien TA, Olsson RF, Patel SS, Perales MA, Prestidge T, Qayed M, Romee R, Schoemans H, Seo S, Sharma A, Solh M, Strair R, Teshima T, Urbano-Ispizua A, Van der Poel M, Vij R, Wagner JL, William B, Wirk B, Yared JA, Spellman SR, Arora M, Hamilton BK) Biol Blood Marrow Transplant 2020 Aug;26(8):1459-1468 PMID: 32434056 PMCID: PMC7391266 SCOPUS ID: 2-s2.0-85086477294 05/21/2020       30 Citations
  • Subsequent neoplasms and late mortality in children undergoing allogeneic transplantation for nonmalignant diseases. (Kahn JM, Brazauskas R, Tecca HR, Bo-Subait S, Buchbinder D, Battiwala M, Flowers MED, Savani BN, Phelan R, Broglie L, Abraham AA, Keating AK, Daly A, Wirk B, George B, Alter BP, Ustun C, Freytes CO, Beitinjaneh AM, Duncan C, Copelan E, Hildebrandt GC, Murthy HS, Lazarus HM, Auletta JJ, Myers KC, Williams KM, Page KM, Vrooman LM, Norkin M, Byrne M, Diaz MA, Kamani N, Bhatt NS, Rezvani A, Farhadfar N, Mehta PA, Hematti P, Shaw PJ, Kamble RT, Schears R, Olsson RF, Hayashi RJ, Gale RP, Mayo SJ, Chhabra S, Rotz SJ, Badawy SM, Ganguly S, Pavletic S, Nishihori T, Prestidge T, Agrawal V, Hogan WJ, Inamoto Y, Shaw BE, Satwani P) Blood Adv 2020 May 12;4(9):2084-2094 PMID: 32396620 PMCID: PMC7218429 SCOPUS ID: 2-s2.0-85086114432 05/13/2020       16 Citations
  • Composite GRFS and CRFS Outcomes After Adult Alternative Donor HCT. (Mehta RS, Holtan SG, Wang T, Hemmer MT, Spellman SR, Arora M, Couriel DR, Alousi AM, Pidala J, Abdel-Azim H, Agrawal V, Ahmed I, Al-Homsi AS, Aljurf M, Antin JH, Askar M, Auletta JJ, Bhatt VR, Chee L, Chhabra S, Daly A, DeFilipp Z, Gajewski J, Gale RP, Gergis U, Hematti P, Hildebrandt GC, Hogan WJ, Inamoto Y, Martino R, Majhail NS, Marks DI, Nishihori T, Olsson RF, Pawarode A, Diaz MA, Prestidge T, Rangarajan HG, Ringden O, Saad A, Savani BN, Schoemans H, Seo S, Schultz KR, Solh M, Spitzer T, Storek J, Teshima T, Verdonck LF, Wirk B, Yared JA, Cahn JY, Weisdorf DJ) J Clin Oncol 2020 Jun 20;38(18):2062-2076 PMID: 32364845 PMCID: PMC7302955 SCOPUS ID: 2-s2.0-85086748427 05/05/2020       32 Citations
  • Therapeutic Effects of Lyophilized Conditioned-Medium Derived from Corneal Mesenchymal Stromal Cells on Corneal Epithelial Wound Healing. (Jabbehdari S, Yazdanpanah G, Kanu LN, Chen E, Kang K, Anwar KN, Ghassemi M, Hematti P, Rosenblatt MI, Djalilian AR) Curr Eye Res 2020 Dec;45(12):1490-1496 PMID: 32338541 PMCID: PMC7666083 SCOPUS ID: 2-s2.0-85085481231 04/28/2020       15 Citations
  • Late effects after ablative allogeneic stem cell transplantation for adolescent and young adult acute myeloid leukemia. (Lee CJ, Kim S, Tecca HR, Bo-Subait S, Phelan R, Brazauskas R, Buchbinder D, Hamilton BK, Battiwalla M, Majhail NS, Lazarus HM, Shaw PJ, Marks DI, Litzow MR, Chhabra S, Inamoto Y, DeFilipp Z, Hildebrandt GC, Olsson RF, Kasow KA, Liesveld JL, Rotz SJ, Badawy SM, Bhatt NS, Yared JA, Page KM, Arellano ML, Kent M, Farhadfar N, Seo S, Hematti P, Freytes CO, Rovó A, Ganguly S, Nathan S, Burns L, Shaw BE, Muffly LS) Blood Adv 2020 Mar 24;4(6):983-992 PMID: 32168378 PMCID: PMC7094022 SCOPUS ID: 2-s2.0-85082533373 03/14/2020       34 Citations
  • Incidence, Risk Factors for and Outcomes of Transplant-Associated Thrombotic Microangiopathy. (Epperla N, Li A, Logan B, Fretham C, Chhabra S, Aljurf M, Chee L, Copelan E, Freytes CO, Hematti P, Lazarus HM, Litzow M, Nishihori T, Olsson RF, Prestidge T, Saber W, Wirk B, Yared JA, Loren A, Pasquini M) Br J Haematol 2020 Jun;189(6):1171-1181 PMID: 32124435 PMCID: PMC7726817 SCOPUS ID: 2-s2.0-85080995146 03/04/2020       61 Citations
  • Weighty choices: selecting optimal G-CSF doses for stem cell mobilization to optimize yield. (Farhadfar N, Hsu JW, Logan BR, Sees JA, Chitphakdithai P, Sugrue MW, Abdel-Azim H, Anderlini PN, Bredeson C, Chhabra S, Diaz MA, Ganguly S, Hematti P, Kamble RT, Kasow KA, Lazarus HM, Lynch DK, Murthy HS, Olsson RF, Papari M, Przepiorka D, Savani BN, Schears R, Seo S, Solh MM, Spitzer T, Yared JA, Pulsipher MA, Shah NN, Switzer GE, Confer DL, Shaw BE, Wingard JR) Blood Adv 2020 Feb 25;4(4):706-716 PMID: 32092138 PMCID: PMC7042992 SCOPUS ID: 2-s2.0-85082202343 02/25/2020       11 Citations
  • Collection of Peripheral Blood Progenitor Cells in 1 Day Is Associated with Decreased Donor Toxicity Compared to 2 Days in Unrelated Donors. (Hsu JW, Shaw BE, Kim S, Logan BR, Sees JA, Confer DL, Pulsipher MA, Shah N, Switzer GE, Abidi MH, Ahmed IA, Anderlini PN, Bredeson C, Chhabra S, Dandoy CE, Diaz MA, Farhadfar N, Ganguly S, Gergis U, Hale GA, Hematti P, Kamble RT, Kasow KA, Lazarus HM, Liesveld JL, Murthy HS, Olsson RF, Savani BN, Schears R, Seo S, Solh M, Spitzer T, Steinberg A, Sugrue M, Warkentin P, Wingard JR) Biol Blood Marrow Transplant 2020 Jun;26(6):1210-1217 PMID: 32088366 PMCID: PMC7347029 SCOPUS ID: 2-s2.0-85082823451 02/24/2020       4 Citations
  • Incidence, Risk Factors, and Outcomes of Patients Who Develop Mucosal Barrier Injury-Laboratory Confirmed Bloodstream Infections in the First 100 Days After Allogeneic Hematopoietic Stem Cell Transplant. (Dandoy CE, Kim S, Chen M, Ahn KW, Ardura MI, Brown V, Chhabra S, Diaz MA, Dvorak C, Farhadfar N, Flagg A, Ganguly S, Hale GA, Hashmi SK, Hematti P, Martino R, Nishihori T, Nusrat R, Olsson RF, Rotz SJ, Sung AD, Perales MA, Lindemans CA, Komanduri KV, Riches ML) JAMA Netw Open 2020 Jan 03;3(1):e1918668 PMID: 31913492 PMCID: PMC6991246 SCOPUS ID: 2-s2.0-85077688075 01/09/2020       36 Citations
  • Immunosuppression-Free Kidney Transplantation: Advancing New Treatments by Building on Our Past Foundations. (Kaufman DB, Hematti P, Golden RN) WMJ 2019 Oct;118(3):146-147 PMID: 31682753 SCOPUS ID: 2-s2.0-85074545836 11/05/2019    
  • Mineral-Coated Microparticles Enhance mRNA-Based Transfection of Human Bone Marrow Cells. (Fontana G, Martin HL, Lee JS, Schill K, Hematti P, Murphy WL) Mol Ther Nucleic Acids 2019 Dec 06;18:455-464 PMID: 31655263 PMCID: PMC6831872 SCOPUS ID: 2-s2.0-85073685355 10/28/2019       12 Citations
  • Myeloablative vs reduced intensity T-cell-replete haploidentical transplantation for hematologic malignancy. (Solomon SR, St Martin A, Shah NN, Fatobene G, Al Malki MM, Ballen KK, Bashey A, Bejanyan N, Bolaños Meade J, Brunstein CG, DeFilipp Z, Champlin RE, Fuchs EJ, Hamadani M, Hematti P, Kanakry CG, McGuirk JP, McNiece IK, Ciurea SO, Pasquini MC, Rocha V, Romee R, Patel SS, Vasu S, Waller EK, Wingard JR, Zhang MJ, Eapen M) Blood Adv 2019 Oct 08;3(19):2836-2844 PMID: 31582392 PMCID: PMC6784523 SCOPUS ID: 2-s2.0-85073446898 10/05/2019       36 Citations
  • Comprehensive Prognostication in Critically Ill Pediatric Hematopoietic Cell Transplant Patients: Results from Merging the Center for International Blood and Marrow Transplant Research (CIBMTR) and Virtual Pediatric Systems (VPS) Registries. (Zinter MS, Logan BR, Fretham C, Sapru A, Abraham A, Aljurf MD, Arnold SD, Artz A, Auletta JJ, Chhabra S, Copelan E, Duncan C, Gale RP, Guinan E, Hematti P, Keating AK, Marks DI, Olsson R, Savani BN, Ustun C, Williams KM, Pasquini MC, Dvorak CC) Biol Blood Marrow Transplant 2020 Feb;26(2):333-342 PMID: 31563573 PMCID: PMC6943183 SCOPUS ID: 2-s2.0-85074484312 09/30/2019       27 Citations
  • Bone Marrow Stromal Cells Transcriptionally Repress ESR1 but Cannot Overcome Constitutive ESR1 Mutant Activity. (Lung DK, Warrick JW, Hematti P, Callander NS, Mark CJ, Miyamoto S, Alarid ET) Endocrinology 2019 Oct 01;160(10):2427-2440 PMID: 31504407 PMCID: PMC6760314 SCOPUS ID: 2-s2.0-85072628742 09/11/2019       4 Citations
  • Comparison of High Doses of Total Body Irradiation in Myeloablative Conditioning before Hematopoietic Cell Transplantation. (Sabloff M, Chhabra S, Wang T, Fretham C, Kekre N, Abraham A, Adekola K, Auletta JJ, Barker C, Beitinjaneh AM, Bredeson C, Cahn JY, Diaz MA, Freytes C, Gale RP, Ganguly S, Gergis U, Guinan E, Hamilton BK, Hashmi S, Hematti P, Hildebrandt G, Holmberg L, Hong S, Lazarus HM, Martino R, Muffly L, Nishihori T, Perales MA, Yared J, Mineishi S, Stadtmauer EA, Pasquini MC, Loren AW) Biol Blood Marrow Transplant 2019 Dec;25(12):2398-2407 PMID: 31473319 PMCID: PMC7304318 SCOPUS ID: 2-s2.0-85072691397 09/02/2019       19 Citations
  • Macrophages Educated with Exosomes from Primed Mesenchymal Stem Cells Treat Acute Radiation Syndrome by Promoting Hematopoietic Recovery. (Kink JA, Forsberg MH, Reshetylo S, Besharat S, Childs CJ, Pederson JD, Gendron-Fitzpatrick A, Graham M, Bates PD, Schmuck EG, Raval A, Hematti P, Capitini CM) Biol Blood Marrow Transplant 2019 Nov;25(11):2124-2133 PMID: 31394269 PMCID: PMC6861683 SCOPUS ID: 2-s2.0-85072691542 08/09/2019       40 Citations
  • Inferior Outcomes with Cyclosporine and Mycophenolate Mofetil after Myeloablative Allogeneic Hematopoietic Cell Transplantation. (Hamilton BK, Liu Y, Hemmer MT, Majhail N, Ringden O, Kim D, Costa L, Stuart R, Alousi A, Pidala JA, Couriel DR, Aljurf M, Antin JH, Bredeson C, Cahn JY, Cairo M, Choi SW, Dandoy C, Gale RP, Gergis U, Hematti P, Inamoto Y, Kamble RT, MacMillan M, Marks DI, Nemecek E, Nishihori T, Saad A, Savani BN, Schriber J, Seo S, Socié G, Teshima T, Verdonck LF, Waller EK, Wirk M, Spellman SR, Arora M, Chhabra S) Biol Blood Marrow Transplant 2019 Sep;25(9):1744-1755 PMID: 31158502 PMCID: PMC7039394 SCOPUS ID: 2-s2.0-85068515130 06/04/2019       9 Citations
  • Potency Analysis of Mesenchymal Stromal Cells Using a Phospho-STAT Matrix Loop Analytical Approach. (Chinnadurai R, Rajakumar A, Schneider AJ, Bushman WA, Hematti P, Galipeau J) Stem Cells 2019 Aug;37(8):1119-1125 PMID: 31108008 PMCID: PMC6729138 SCOPUS ID: 2-s2.0-85067048864 05/21/2019       21 Citations
  • Impact of T Cell Dose on Outcome of T Cell-Replete HLA-Matched Allogeneic Peripheral Blood Stem Cell Transplantation. (Saad A, Lamb L, Wang T, Hemmer MT, Spellman S, Couriel D, Alousi A, Pidala J, Abdel-Azim H, Agrawal V, Aljurf M, Beitinjaneh AM, Bhatt VR, Buchbinder D, Byrne M, Cahn JY, Cairo M, Castillo P, Chhabra S, Diaz MA, Farhan S, Floisand Y, Frangoul HA, Gadalla SM, Gajewski J, Gale RP, Gandhi M, Gergis U, Hamilton BK, Hematti P, Hildebrandt GC, Kamble RT, Kanate AS, Khandelwal P, Lazaryan A, MacMillan M, Marks DI, Martino R, Mehta PA, Nishihori T, Olsson RF, Patel SS, Qayed M, Rangarajan HG, Reshef R, Ringden O, Savani BN, Schouten HC, Schultz KR, Seo S, Shaffer BC, Solh M, Teshima T, Urbano-Ispizua A, Verdonck LF, Vij R, Waller EK, William B, Wirk B, Yared JA, Yu LC, Arora M, Hashmi S) Biol Blood Marrow Transplant 2019 Sep;25(9):1875-1883 PMID: 31085303 PMCID: PMC7071947 SCOPUS ID: 2-s2.0-85066874770 05/16/2019       12 Citations
  • GRFS and CRFS in alternative donor hematopoietic cell transplantation for pediatric patients with acute leukemia. (Mehta RS, Holtan SG, Wang T, Hemmer MT, Spellman SR, Arora M, Couriel DR, Alousi AM, Pidala J, Abdel-Azim H, Ahmed I, Aljurf M, Askar M, Auletta JJ, Bhatt V, Bredeson C, Chhabra S, Gadalla S, Gajewski J, Gale RP, Gergis U, Hematti P, Hildebrandt GC, Inamoto Y, Kitko C, Khandelwal P, MacMillan ML, Majhail N, Marks DI, Mehta P, Nishihori T, Olsson RF, Pawarode A, Diaz MA, Prestidge T, Qayed M, Rangarajan H, Ringden O, Saad A, Savani BN, Seo S, Shah A, Shah N, Schultz KR, Solh M, Spitzer T, Szer J, Teshima T, Verdonck LF, Williams KM, Wirk B, Wagner J, Yared JA, Weisdorf DJ) Blood Adv 2019 May 14;3(9):1441-1449 PMID: 31053571 PMCID: PMC6517657 SCOPUS ID: 2-s2.0-85068626630 05/06/2019       11 Citations
  • Survival Trends in Infants Undergoing Allogeneic Hematopoietic Cell Transplant. (Parikh SH, Satwani P, Ahn KW, Sahr NA, Fretham C, Abraham AA, Agrawal V, Auletta JJ, Abdel-Azim H, Copelan E, Diaz MA, Dvorak CC, Frangoul HA, Freytes CO, Gadalla SM, Gale RP, George B, Gergis U, Hashmi S, Hematti P, Hildebrandt GC, Keating AK, Lazarus HM, Myers KC, Olsson RF, Prestidge T, Rotz SJ, Savani BN, Shereck EB, Williams KM, Wirk B, Pasquini MC, Loren AW) JAMA Pediatr 2019 May 01;173(5):e190081 PMID: 30882883 PMCID: PMC6503511 SCOPUS ID: 2-s2.0-85062953980 03/19/2019       11 Citations
  • Versican proteolysis predicts immune effector infiltration and post-transplant survival in myeloma. (Dhakal B, Pagenkopf A, Mushtaq MU, Cunningham AM, Flietner E, Morrow Z, Papadas A, Hope C, Leith C, Hematti P, Hari P, Callander NS, Asimakopoulos F) Leuk Lymphoma 2019 Oct;60(10):2558-2562 PMID: 30845856 PMCID: PMC7176050 SCOPUS ID: 2-s2.0-85062788299 03/09/2019       12 Citations
  • Correction: Non-GVHD ocular complications after hematopoietic cell transplantation: expert review from the Late Effects and Quality of Life Working Committee of the CIBMTR and Transplant Complications Working Party of the EBMT. (Inamoto Y, Petriček I, Burns L, Chhabra S, DeFilipp Z, Hematti P, Rovó A, Schears R, Shah A, Agrawal V, Al-Khinji A, Ahmed I, Ali A, Aljurf M, Alkhateeb H, Beitinjaneh A, Bhatt N, Buchbinder D, Byrne M, Callander N, Fahnehjelm K, Farhadfar N, Gale RP, Ganguly S, Hildebrandt GC, Horn E, Jakubowski A, Kamble RT, Law J, Lee C, Nathan S, Penack O, Pingali R, Prasad P, Pulanic D, Rotz S, Shreenivas A, Steinberg A, Tabbara K, Tichelli A, Wirk B, Yared J, Basak GW, Battiwalla M, Duarte R, Savani BN, Flowers MED, Shaw BE, Valdés-Sanz N) Bone Marrow Transplant 2019 May;54(5):782-783 PMID: 30809032 SCOPUS ID: 2-s2.0-85062277875 02/28/2019       1 Citation
  • Extracellular Vesicle-Educated Macrophages Promote Early Achilles Tendon Healing. (Chamberlain CS, Clements AEB, Kink JA, Choi U, Baer GS, Halanski MA, Hematti P, Vanderby R) Stem Cells 2019 May;37(5):652-662 PMID: 30720911 PMCID: PMC6850358 SCOPUS ID: 2-s2.0-85061977038 02/06/2019       123 Citations
  • The Concentration of Total Nucleated Cells in Harvested Bone Marrow for Transplantation Has Decreased over Time. (Prokopishyn NL, Logan BR, Kiefer DM, Sees JA, Chitphakdithai P, Ahmed IA, Anderlini PN, Beitinjaneh AM, Bredeson C, Cerny J, Chhabra S, Daly A, Diaz MA, Farhadfar N, Frangoul HA, Ganguly S, Gastineau DA, Gergis U, Hale GA, Hematti P, Kamble RT, Kasow KA, Lazarus HM, Liesveld JL, Murthy HS, Norkin M, Olsson RF, Papari M, Savani BN, Szer J, Waller EK, Wirk B, Yared JA, Pulsipher MA, Shah NN, Switzer GE, O'Donnell PV, Confer DL, Shaw BE) Biol Blood Marrow Transplant 2019 Jul;25(7):1325-1330 PMID: 30716454 PMCID: PMC6615955 SCOPUS ID: 2-s2.0-85062227022 02/05/2019       14 Citations
  • Non-GVHD ocular complications after hematopoietic cell transplantation: expert review from the Late Effects and Quality of Life Working Committee of the CIBMTR and Transplant Complications Working Party of the EBMT. (Inamoto Y, Petriček I, Burns L, Chhabra S, DeFilipp Z, Hematti P, Rovó A, Schears R, Shah A, Agrawal V, Al-Khinji A, Ahmed I, Ali A, Aljurf M, Alkhateeb H, Beitinjaneh A, Bhatt N, Buchbinder D, Byrne M, Callander N, Fahnehjelm K, Farhadfar N, Gale RP, Ganguly S, Hildebrandt GC, Horn E, Jakubowski A, Kamble RT, Law J, Lee C, Nathan S, Penack O, Pingali R, Prasad P, Pulanic D, Rotz S, Shreenivas A, Steinberg A, Tabbara K, Tichelli A, Wirk B, Yared J, Basak GW, Battiwalla M, Duarte R, Savani BN, Flowers MED, Shaw BE, Valdés-Sanz N) Bone Marrow Transplant 2019 May;54(5):648-661 PMID: 30531955 PMCID: PMC6497536 SCOPUS ID: 2-s2.0-85058153231 12/12/2018       15 Citations
  • Non-Graft-versus-Host Disease Ocular Complications after Hematopoietic Cell Transplantation: Expert Review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and the Transplant Complications Working Party of the European Society for Blood and Marrow Transplantation. (Inamoto Y, Petriček I, Burns L, Chhabra S, DeFilipp Z, Hematti P, Rovó A, Schears R, Shah A, Agrawal V, Ahmed A, Ahmed I, Ali A, Aljurf M, Alkhateeb H, Beitinjaneh A, Bhatt N, Buchbinder D, Byrne M, Callander N, Fahnehjelm K, Farhadfar N, Gale RP, Ganguly S, Hashmi S, Hildebrandt GC, Horn E, Jakubowski A, Kamble RT, Law J, Lee C, Nathan S, Penack O, Pingali R, Prasad P, Pulanic D, Rotz S, Shreenivas A, Steinberg A, Tabbara K, Tichelli A, Wirk B, Yared J, Basak GW, Battiwalla M, Duarte R, Savani BN, Flowers MED, Shaw BE, Valdés-Sanz N) Biol Blood Marrow Transplant 2019 May;25(5):e145-e154 PMID: 30521975 PMCID: PMC6511311 SCOPUS ID: 2-s2.0-85059228103 12/07/2018       13 Citations
  • Effect of Conditioning Regimen Dose Reduction in Obese Patients Undergoing Autologous Hematopoietic Cell Transplantation. (Brunstein CG, Pasquini MC, Kim S, Fei M, Adekola K, Ahmed I, Aljurf M, Agrawal V, Auletta JJ, Battiwalla M, Bejanyan N, Bubalo J, Cerny J, Chee L, Ciurea SO, Freytes C, Gadalla SM, Gale RP, Ganguly S, Hashmi SK, Hematti P, Hildebrandt G, Holmberg LA, Lahoud OB, Landau H, Lazarus HM, de Lima M, Mathews V, Maziarz R, Nishihori T, Norkin M, Olsson R, Reshef R, Rotz S, Savani B, Schouten HC, Seo S, Wirk BM, Yared J, Mineishi S, Rogosheske J, Perales MA) Biol Blood Marrow Transplant 2019 Mar;25(3):480-487 PMID: 30423481 PMCID: PMC6445718 SCOPUS ID: 2-s2.0-85058228349 11/14/2018       9 Citations
  • Effect of Human Corneal Mesenchymal Stromal Cell-derived Exosomes on Corneal Epithelial Wound Healing. (Samaeekia R, Rabiee B, Putra I, Shen X, Park YJ, Hematti P, Eslani M, Djalilian AR) Invest Ophthalmol Vis Sci 2018 Oct 01;59(12):5194-5200 PMID: 30372747 PMCID: PMC6203220 SCOPUS ID: 2-s2.0-85055612884 10/30/2018       151 Citations
  • Characteristics of Late Fatal Infections after Allogeneic Hematopoietic Cell Transplantation. (Norkin M, Shaw BE, Brazauskas R, Tecca HR, Leather HL, Gea-Banacloche J, T Kamble R, DeFilipp Z, Jacobsohn DA, Ringden O, Inamoto Y, A Kasow K, Buchbinder D, Shaw P, Hematti P, Schears R, Badawy SM, Lazarus HM, Bhatt N, Horn B, Chhabra S, M Page K, Hamilton B, Hildebrandt GC, Yared JA, Agrawal V, M Beitinjaneh A, Majhail N, Kindwall-Keller T, Olsson RF, Schoemans H, Gale RP, Ganguly S, A Ahmed I, Schouten HC, L Liesveld J, Khera N, Steinberg A, Shah AJ, Solh M, Marks DI, Rybka W, Aljurf M, Dietz AC, Gergis U, George B, Seo S, Flowers MED, Battiwalla M, Savani BN, Riches ML, Wingard JR) Biol Blood Marrow Transplant 2019 Feb;25(2):362-368 PMID: 30287390 PMCID: PMC6339825 SCOPUS ID: 2-s2.0-85055972080 10/06/2018       33 Citations
  • Role of Extracellular Matrix in Cardiac Cellular Therapies. (Hematti P) Adv Exp Med Biol 2018;1098:173-188 PMID: 30238371 SCOPUS ID: 2-s2.0-85053756706 09/22/2018       6 Citations
  • TCR αβ+/CD19+ cell depletion in haploidentical hematopoietic allogeneic stem cell transplantation: a review of current data. (Sahasrabudhe K, Otto M, Hematti P, Kenkre V) Leuk Lymphoma 2019 Mar;60(3):598-609 PMID: 30187806 PMCID: PMC6764418 SCOPUS ID: 2-s2.0-85053267183 09/07/2018       9 Citations
  • Comparative Analysis of Calcineurin Inhibitor-Based Methotrexate and Mycophenolate Mofetil-Containing Regimens for Prevention of Graft-versus-Host Disease after Reduced-Intensity Conditioning Allogeneic Transplantation. (Chhabra S, Liu Y, Hemmer MT, Costa L, Pidala JA, Couriel DR, Alousi AM, Majhail NS, Stuart RK, Kim D, Ringden O, Urbano-Ispizua A, Saad A, Savani BN, Cooper B, Marks DI, Socie G, Schouten HC, Schoemans H, Abdel-Azim H, Yared J, Cahn JY, Wagner J, Antin JH, Verdonck LF, Lehmann L, Aljurf MD, MacMillan ML, Litzow MR, Solh MM, Qayed M, Hematti P, Kamble RT, Vij R, Hayashi RJ, Gale RP, Martino R, Seo S, Hashmi SK, Nishihori T, Teshima T, Gergis U, Inamoto Y, Spellman SR, Arora M, Hamilton BK) Biol Blood Marrow Transplant 2019 Jan;25(1):73-85 PMID: 30153491 PMCID: PMC6355336 SCOPUS ID: 2-s2.0-85054156982 08/29/2018       32 Citations
  • GATA/Heme Multi-omics Reveals a Trace Metal-Dependent Cellular Differentiation Mechanism. (Tanimura N, Liao R, Wilson GM, Dent MR, Cao M, Burstyn JN, Hematti P, Liu X, Zhang Y, Zheng Y, Keles S, Xu J, Coon JJ, Bresnick EH) Dev Cell 2018 Sep 10;46(5):581-594.e4 PMID: 30122630 PMCID: PMC6133724 SCOPUS ID: 2-s2.0-85053858322 08/21/2018       29 Citations
  • Intraperitoneal injection of MSC-derived exosomes prevent experimental bronchopulmonary dysplasia. (Braun RK, Chetty C, Balasubramaniam V, Centanni R, Haraldsdottir K, Hematti P, Eldridge MW) Biochem Biophys Res Commun 2018 Sep 18;503(4):2653-2658 PMID: 30093115 PMCID: PMC6398932 SCOPUS ID: 2-s2.0-85051014878 08/11/2018       91 Citations
  • Risk of acute myeloid leukemia and myelodysplastic syndrome after autotransplants for lymphomas and plasma cell myeloma. (Radivoyevitch T, Dean RM, Shaw BE, Brazauskas R, Tecca HR, Molenaar RJ, Battiwalla M, Savani BN, Flowers MED, Cooke KR, Hamilton BK, Kalaycio M, Maciejewski JP, Ahmed I, Akpek G, Bajel A, Buchbinder D, Cahn JY, D'Souza A, Daly A, DeFilipp Z, Ganguly S, Hamadani M, Hayashi RJ, Hematti P, Inamoto Y, Khera N, Kindwall-Keller T, Landau H, Lazarus H, Majhail NS, Marks DI, Olsson RF, Seo S, Steinberg A, William BM, Wirk B, Yared JA, Aljurf M, Abidi MH, Allewelt H, Beitinjaneh A, Cook R, Cornell RF, Fay JW, Hale G, Chakrabarty JH, Jodele S, Kasow KA, Mahindra A, Malone AK, Popat U, Rizzo JD, Schouten HC, Warwick AB, Wood WA, Sekeres MA, Litzow MR, Gale RP, Hashmi SK) Leuk Res 2018 Nov;74:130-136 PMID: 30055822 PMCID: PMC6219911 SCOPUS ID: 2-s2.0-85050340275 07/30/2018       40 Citations
  • Donor body mass index does not predict graft versus host disease following hematopoietic cell transplantation. (Turcotte LM, Wang T, Hemmer MT, Spellman SR, Arora M, Couriel D, Alousi A, Pidala J, Abdel-Azim H, Ahmed I, Beitinjaneh A, Buchbinder D, Byrne M, Callander N, Chao N, Choi SW, DeFilipp Z, Gadalla SM, Gale RP, Gergis U, Hashmi S, Hematti P, Holmberg L, Inamoto Y, Kamble RT, Lehmann L, MacMillan MA, McIver Z, Nishihori T, Norkin M, O'Brien T, Olsson RF, Reshef R, Saad A, Savani BN, Schouten HC, Seo S, Solh M, Verdonck L, Vij R, Wirk B, Yared J, Horowitz MM, Knight JM, Verneris MR) Bone Marrow Transplant 2018 Jul;53(7):932-937 PMID: 29382954 PMCID: PMC6041147 SCOPUS ID: 2-s2.0-85041181961 02/01/2018       2 Citations
  • Cornea-Derived Mesenchymal Stromal Cells Therapeutically Modulate Macrophage Immunophenotype and Angiogenic Function. (Eslani M, Putra I, Shen X, Hamouie J, Tadepalli A, Anwar KN, Kink JA, Ghassemi S, Agnihotri G, Reshetylo S, Mashaghi A, Dana R, Hematti P, Djalilian AR) Stem Cells 2018 May;36(5):775-784 PMID: 29341332 PMCID: PMC5918156 SCOPUS ID: 2-s2.0-85041074081 01/18/2018       46 Citations
  • Blockade of BAFF Receptor BR3 on T Cells Enhances Their Activation and Cytotoxicity. (Bloom DD, Reshetylo S, Nytes C, Goodsett CT, Hematti P) J Immunother 2018 Jun;41(5):213-223 PMID: 29309290 PMCID: PMC5943136 SCOPUS ID: 2-s2.0-85047247495 01/09/2018       7 Citations
  • Hyaluronan and proteoglycan link protein 1 (HAPLN1) activates bortezomib-resistant NF-κB activity and increases drug resistance in multiple myeloma. (Huynh M, Pak C, Markovina S, Callander NS, Chng KS, Wuerzberger-Davis SM, Bakshi DD, Kink JA, Hematti P, Hope C, Asimakopoulos F, Rui L, Miyamoto S) J Biol Chem 2018 Feb 16;293(7):2452-2465 PMID: 29279332 PMCID: PMC5818187 SCOPUS ID: 2-s2.0-85042184901 12/28/2017       28 Citations
  • Influence of Age on Acute and Chronic GVHD in Children Undergoing HLA-Identical Sibling Bone Marrow Transplantation for Acute Leukemia: Implications for Prophylaxis. (Qayed M, Wang T, Hemmer MT, Spellman S, Arora M, Couriel D, Alousi A, Pidala J, Abdel-Azim H, Aljurf M, Ayas M, Bitan M, Cairo M, Choi SW, Dandoy C, Delgado D, Gale RP, Hale G, Frangoul H, Kamble RT, Kharfan-Dabaja M, Lehman L, Levine J, MacMillan M, Marks DI, Nishihori T, Olsson RF, Hematti P, Ringden O, Saad A, Satwani P, Savani BN, Schultz KR, Seo S, Shenoy S, Waller EK, Yu L, Horowitz MM, Horan J) Biol Blood Marrow Transplant 2018 Mar;24(3):521-528 PMID: 29155316 PMCID: PMC5826854 SCOPUS ID: 2-s2.0-85039159224 11/21/2017       33 Citations
  • Corneal Mesenchymal Stromal Cells Are Directly Antiangiogenic via PEDF and sFLT-1. (Eslani M, Putra I, Shen X, Hamouie J, Afsharkhamseh N, Besharat S, Rosenblatt MI, Dana R, Hematti P, Djalilian AR) Invest Ophthalmol Vis Sci 2017 Oct 01;58(12):5507-5517 PMID: 29075761 PMCID: PMC5661382 SCOPUS ID: 2-s2.0-85032588253 10/28/2017       52 Citations
  • Donor Experiences of Second Marrow or Peripheral Blood Stem Cell Collection Mirror the First, but CD34+ Yields Are Less. (Stroncek DF, Shaw BE, Logan BR, Kiefer DM, Savani BN, Anderlini P, Bredeson CN, Hematti P, Ganguly S, Diaz MA, Abdel-Azim H, Ahmed I, Maharaj D, Seftel M, Beitinjaneh A, Seo S, Yared JA, Halter J, O'Donnell PV, Hale GA, DeFilipp Z, Lazarus H, Liesveld JL, Zhou Z, Munshi P, Olsson RF, Kasow KA, Szer J, Switzer GE, Chitphakdithai P, Shah N, Confer DL, Pulsipher MA) Biol Blood Marrow Transplant 2018 Jan;24(1):175-184 PMID: 28958894 PMCID: PMC5743544 SCOPUS ID: 2-s2.0-85033230771 09/30/2017       5 Citations
  • Bioengineering Solutions for Manufacturing Challenges in CAR T Cells. (Piscopo NJ, Mueller KP, Das A, Hematti P, Murphy WL, Palecek SP, Capitini CM, Saha K) Biotechnol J 2018 Feb;13(2) PMID: 28840981 PMCID: PMC5796845 SCOPUS ID: 2-s2.0-85041315749 08/26/2017       57 Citations
  • Versican-Derived Matrikines Regulate Batf3-Dendritic Cell Differentiation and Promote T Cell Infiltration in Colorectal Cancer. (Hope C, Emmerich PB, Papadas A, Pagenkopf A, Matkowskyj KA, Van De Hey DR, Payne SN, Clipson L, Callander NS, Hematti P, Miyamoto S, Johnson MG, Deming DA, Asimakopoulos F) J Immunol 2017 Sep 01;199(5):1933-1941 PMID: 28754680 PMCID: PMC5568487 SCOPUS ID: 2-s2.0-85028024683 07/30/2017       70 Citations
  • Minocycline modulates NFκB phosphorylation and enhances antimicrobial activity against Staphylococcus aureus in mesenchymal stromal/stem cells. (Guerra AD, Rose WE, Hematti P, Kao WJ) Stem Cell Res Ther 2017 Jul 21;8(1):171 PMID: 28732530 PMCID: PMC5521110 SCOPUS ID: 2-s2.0-85025160429 07/25/2017       15 Citations
  • Corrigendum to "Thiol-ene Michael-type formation of gelatin/poly(ethylene glycol) biomatrices for three-dimensional mesenchymal stromal/stem cell administration to cutaneous wounds" [Acta Biomater. 9(11) (2013) 8802-8814]. (Xu K, Cantu DA, Fu Y, Kim J, Zheng X, Hematti P, Kao WJ) Acta Biomater 2017 Aug;58:561 PMID: 28698026 SCOPUS ID: 2-s2.0-85021920503 07/13/2017    
  • WITHDRAWN: Corrigendum to "Thiol-ene Michael-type formation of gelatin/poly(ethylene glycol) biomatrices for three-dimensional mesenchymal stromal/stem cell administration to cutaneous wounds" [Acta Biomater. 9(11) (2013) 8802-8814]. (Xu K, Cantu DA, Fu Y, Kim J, Zheng X, Hematti P, Kao WJ) Acta Biomater 2017 Jun 23 PMID: 28648565 06/27/2017    
  • Survival and Late Effects after Allogeneic Hematopoietic Cell Transplantation for Hematologic Malignancy at Less than Three Years of Age. (Vrooman LM, Millard HR, Brazauskas R, Majhail NS, Battiwalla M, Flowers ME, Savani BN, Akpek G, Aljurf M, Bajwa R, Baker KS, Beitinjaneh A, Bitan M, Buchbinder D, Chow E, Dandoy C, Dietz AC, Diller L, Gale RP, Hashmi SK, Hayashi RJ, Hematti P, Kamble RT, Kasow KA, Kletzel M, Lazarus HM, Malone AK, Marks DI, O'Brien TA, Olsson RF, Ringden O, Seo S, Steinberg A, Yu LC, Warwick A, Shaw B, Duncan C) Biol Blood Marrow Transplant 2017 Aug;23(8):1327-1334 PMID: 28461213 PMCID: PMC5666571 SCOPUS ID: 2-s2.0-85021731451 05/04/2017       37 Citations
  • Manufacturing Differences Affect Human Bone Marrow Stromal Cell Characteristics and Function: Comparison of Production Methods and Products from Multiple Centers. (Liu S, de Castro LF, Jin P, Civini S, Ren J, Reems JA, Cancelas J, Nayak R, Shaw G, O'Brien T, McKenna DH, Armant M, Silberstein L, Gee AP, Hei DJ, Hematti P, Kuznetsov SA, Robey PG, Stroncek DF) Sci Rep 2017 Apr 27;7:46731 PMID: 28447618 PMCID: PMC5406832 SCOPUS ID: 2-s2.0-85032747557 04/28/2017       64 Citations
  • Improved survival after acute graft-versus-host disease diagnosis in the modern era. (Khoury HJ, Wang T, Hemmer MT, Couriel D, Alousi A, Cutler C, Aljurf M, Antin JH, Ayas M, Battiwalla M, Cahn JY, Cairo M, Chen YB, Gale RP, Hashmi S, Hayashi RJ, Jagasia M, Juckett M, Kamble RT, Kharfan-Dabaja M, Litzow M, Majhail N, Miller A, Nishihori T, Qayed M, Schoemans H, Schouten HC, Socie G, Storek J, Verdonck L, Vij R, Wood WA, Yu L, Martino R, Carabasi M, Dandoy C, Gergis U, Hematti P, Solh M, Jamani K, Lehmann L, Savani B, Schultz KR, Wirk BM, Spellman S, Arora M, Pidala J) Haematologica 2017 May;102(5):958-966 PMID: 28302712 PMCID: PMC5477615 SCOPUS ID: 2-s2.0-85018996819 03/18/2017       76 Citations
  • Human Mesenchymal Stem Cell-Educated Macrophages Are a Distinct High IL-6-Producing Subset that Confer Protection in Graft-versus-Host-Disease and Radiation Injury Models. (Bouchlaka MN, Moffitt AB, Kim J, Kink JA, Bloom DD, Love C, Dave S, Hematti P, Capitini CM) Biol Blood Marrow Transplant 2017 Jun;23(6):897-905 PMID: 28257800 PMCID: PMC5499382 SCOPUS ID: 2-s2.0-85016520702 03/05/2017       48 Citations
  • Extracellular Superoxide Dismutase Expression in Papillary Thyroid Cancer Mesenchymal Stem/Stromal Cells Modulates Cancer Cell Growth and Migration. (Parascandolo A, Rappa F, Cappello F, Kim J, Cantu DA, Chen H, Mazzoccoli G, Hematti P, Castellone MD, Salvatore M, Laukkanen MO) Sci Rep 2017 Feb 20;7:41416 PMID: 28216675 PMCID: PMC5316948 SCOPUS ID: 2-s2.0-85013347187 02/22/2017       29 Citations
  • The effect of inter-unit HLA matching in double umbilical cord blood transplantation for acute leukemia. (Brunstein C, Zhang MJ, Barker J, St Martin A, Bashey A, de Lima M, Dehn J, Hematti P, Perales MA, Rocha V, Territo M, Weisdorf D, Eapen M) Haematologica 2017 May;102(5):941-947 PMID: 28126967 PMCID: PMC5477613 SCOPUS ID: 2-s2.0-85018992448 01/28/2017       14 Citations
  • Minocycline enhances the mesenchymal stromal/stem cell pro-healing phenotype in triple antimicrobial-loaded hydrogels. (Guerra AD, Rose WE, Hematti P, Kao WJ) Acta Biomater 2017 Mar 15;51:184-196 PMID: 28069512 PMCID: PMC5704963 SCOPUS ID: 2-s2.0-85009986075 01/11/2017       21 Citations
  • Mesenchymal Stromal Cells: Clinical Experience, Challenges, and Future Directions (Hematti P) Mesenchymal Stromal Cells: Translational Pathways to Clinical Adoption 1 January 2017:309-334 SCOPUS ID: 2-s2.0-85079290276 01/01/2017       1 Citation
  • Mesenchymal Stromal Cells: Translational Pathways to Clinical Adoption (Viswanathan S, Hematti P) Mesenchymal Stromal Cells: Translational Pathways to Clinical Adoption 1 January 2017:1-346 SCOPUS ID: 2-s2.0-85061379117 01/01/2017       2 Citations
  • Therapeutic Purposes and Risks of Ex Vivo Expanded Mesenchymal Stem/Stromal Cells (Bouchlaka MN, Hematti P, Capitini CM) Mesenchymal Stromal Cells as Tumor Stromal Modulators 2017:551-587 SCOPUS ID: 2-s2.0-85021973906 01/01/2017       5 Citations
  • Collection of hematopoietic CD34 stem cells in rhesus macaques using Spectra Optia. (Haynes LD, Coonen J, Post J, Brunner K, Bloom D, Hematti P, Kaufman DB) J Clin Apher 2017 Oct;32(5):288-294 PMID: 27578423 PMCID: PMC5332349 SCOPUS ID: 2-s2.0-84992358028 09/01/2016       6 Citations
  • Autologous Bone Marrow-Derived Mesenchymal Stem Cells Modulate Molecular Markers of Inflammation in Dogs with Cruciate Ligament Rupture. (Muir P, Hans EC, Racette M, Volstad N, Sample SJ, Heaton C, Holzman G, Schaefer SL, Bloom DD, Bleedorn JA, Hao Z, Amene E, Suresh M, Hematti P) PLoS One 2016;11(8):e0159095 PMID: 27575050 PMCID: PMC5005014 SCOPUS ID: 2-s2.0-84991457669 08/31/2016       38 Citations
  • Biodistribution and Clearance of Human Mesenchymal Stem Cells by Quantitative Three-Dimensional Cryo-Imaging After Intravenous Infusion in a Rat Lung Injury Model. (Schmuck EG, Koch JM, Centanni JM, Hacker TA, Braun RK, Eldridge M, Hei DJ, Hematti P, Raval AN) Stem Cells Transl Med 2016 Dec;5(12):1668-1675 PMID: 27460855 PMCID: PMC5189648 SCOPUS ID: 2-s2.0-84995912366 07/28/2016       44 Citations
  • Effects of Oxidative Stress on Mesenchymal Stem Cell Biology. (Denu RA, Hematti P) Oxid Med Cell Longev 2016;2016:2989076 PMID: 27413419 PMCID: PMC4928004 SCOPUS ID: 2-s2.0-84976603510 07/15/2016       238 Citations
  • Safety and efficacy of autologous serum eye drop for treatment of dry eyes in graft-versus-host disease. (Azari AA, Karadag R, Kanavi MR, Nehls S, Barney N, Kim K, Longo W, Hematti P, Juckett M) Cutan Ocul Toxicol 2017 Jun;36(2):152-156 PMID: 27380960 SCOPUS ID: 2-s2.0-84979503425 07/07/2016       10 Citations
  • Immunoregulatory roles of versican proteolysis in the myeloma microenvironment. (Hope C, Foulcer S, Jagodinsky J, Chen SX, Jensen JL, Patel S, Leith C, Maroulakou I, Callander N, Miyamoto S, Hematti P, Apte SS, Asimakopoulos F) Blood 2016 Aug 04;128(5):680-5 PMID: 27259980 PMCID: PMC4974200 SCOPUS ID: 2-s2.0-84982886901 06/05/2016       109 Citations
  • Fibroblasts and Mesenchymal Stromal/Stem Cells Are Phenotypically Indistinguishable. (Denu RA, Nemcek S, Bloom DD, Goodrich AD, Kim J, Mosher DF, Hematti P) Acta Haematol 2016;136(2):85-97 PMID: 27188909 PMCID: PMC4988914 SCOPUS ID: 2-s2.0-84969705729 05/18/2016       162 Citations
  • Characterization of mesenchymal stromal cells: potency assay development. (Hematti P) Transfusion 2016 Apr;56(4):32S-5S PMID: 27079322 SCOPUS ID: 2-s2.0-84963601463 04/16/2016       25 Citations
  • Cardiopulmonary and histological characterization of an acute rat lung injury model demonstrating safety of mesenchymal stromal cell infusion. (Braun RK, Koch JM, Hacker TA, Pegelow D, Kim J, Raval AN, Schmuck EG, Schwahn DJ, Hei DJ, Centanni JM, Eldridge M, Hematti P) Cytotherapy 2016 Apr;18(4):536-45 PMID: 26971682 PMCID: PMC4811186 SCOPUS ID: 2-s2.0-84960103200 03/15/2016       9 Citations
  • International Society for Cellular Therapy perspective on immune functional assays for mesenchymal stromal cells as potency release criterion for advanced phase clinical trials. (Galipeau J, Krampera M, Barrett J, Dazzi F, Deans RJ, DeBruijn J, Dominici M, Fibbe WE, Gee AP, Gimble JM, Hematti P, Koh MB, LeBlanc K, Martin I, McNiece IK, Mendicino M, Oh S, Ortiz L, Phinney DG, Planat V, Shi Y, Stroncek DF, Viswanathan S, Weiss DJ, Sensebe L) Cytotherapy 2016 Feb;18(2):151-9 PMID: 26724220 PMCID: PMC4745114 SCOPUS ID: 2-s2.0-84962117259 01/03/2016       366 Citations
  • Loss of SIRT3 Provides Growth Advantage for B Cell Malignancies. (Yu W, Denu RA, Krautkramer KA, Grindle KM, Yang DT, Asimakopoulos F, Hematti P, Denu JM) J Biol Chem 2016 Feb 12;291(7):3268-79 PMID: 26631723 PMCID: PMC4751373 SCOPUS ID: 2-s2.0-84964680484 12/04/2015       71 Citations
  • Significant Improvements in the Practice Patterns of Adult Related Donor Care in US Transplantation Centers. (Anthias C, Shaw BE, Kiefer DM, Liesveld JL, Yared J, Kamble RT, D'Souza A, Hematti P, Seftel MD, Norkin M, DeFilipp Z, Kasow KA, Abidi MH, Savani BN, Shah NN, Anderlini P, Diaz MA, Malone AK, Halter JP, Lazarus HM, Logan BR, Switzer GE, Pulsipher MA, Confer DL, O'Donnell PV) Biol Blood Marrow Transplant 2016 Mar;22(3):520-7 PMID: 26597080 PMCID: PMC4760616 SCOPUS ID: 2-s2.0-84954290281 11/26/2015       11 Citations
  • Intravenous Followed by X-ray Fused with MRI-Guided Transendocardial Mesenchymal Stem Cell Injection Improves Contractility Reserve in a Swine Model of Myocardial Infarction. (Schmuck EG, Koch JM, Hacker TA, Hatt CR, Tomkowiak MT, Vigen KK, Hendren N, Leitzke C, Zhao YQ, Li Z, Centanni JM, Hei DJ, Schwahn D, Kim J, Hematti P, Raval AN) J Cardiovasc Transl Res 2015 Oct;8(7):438-48 PMID: 26374144 PMCID: PMC5006679 SCOPUS ID: 2-s2.0-84945466674 09/17/2015       16 Citations
  • Analysis of the Effect of Race, Socioeconomic Status, and Center Size on Unrelated National Marrow Donor Program Donor Outcomes: Donor Toxicities Are More Common at Low-Volume Bone Marrow Collection Centers. (Shaw BE, Logan BR, Kiefer DM, Chitphakdithai P, Pedersen TL, Abdel-Azim H, Abidi MH, Akpek G, Diaz MA, Artz AS, Dandoy C, Gajewski JL, Hematti P, Kamble RT, Kasow KA, Lazarus HM, Liesveld JL, Majhail NS, O'Donnell PV, Olsson RF, Savani BN, Schears RM, Stroncek DF, Switzer GE, Williams EP, Wingard JR, Wirk BM, Confer DL, Pulsipher MA) Biol Blood Marrow Transplant 2015 Oct;21(10):1830-8 PMID: 26116089 PMCID: PMC4568129 SCOPUS ID: 2-s2.0-84941317226 06/28/2015       11 Citations
  • Single-molecule analysis reveals widespread structural variation in multiple myeloma. (Gupta A, Place M, Goldstein S, Sarkar D, Zhou S, Potamousis K, Kim J, Flanagan C, Li Y, Newton MA, Callander NS, Hematti P, Bresnick EH, Ma J, Asimakopoulos F, Schwartz DC) Proc Natl Acad Sci U S A 2015 Jun 23;112(25):7689-94 PMID: 26056298 PMCID: PMC4485118 SCOPUS ID: 2-s2.0-84934943864 06/10/2015       40 Citations
  • Tumoricidal Effects of Macrophage-Activating Immunotherapy in a Murine Model of Relapsed/Refractory Multiple Myeloma. (Jensen JL, Rakhmilevich A, Heninger E, Broman AT, Hope C, Phan F, Miyamoto S, Maroulakou I, Callander N, Hematti P, Chesi M, Bergsagel PL, Sondel P, Asimakopoulos F) Cancer Immunol Res 2015 Aug;3(8):881-90 PMID: 25941352 PMCID: PMC4527950 SCOPUS ID: 2-s2.0-84962018269 05/06/2015       24 Citations
  • Mesenchymal Stromal/Stem Cell and Minocycline-Loaded Hydrogels Inhibit the Growth of Staphylococcus aureus that Evades Immunomodulation of Blood-Derived Leukocytes. (Guerra AD, Cantu DA, Vecchi JT, Rose WE, Hematti P, Kao WJ) AAPS J 2015 May;17(3):620-30 PMID: 25716147 PMCID: PMC4406954 SCOPUS ID: 2-s2.0-84939935586 02/27/2015       14 Citations
  • MSC-regulated microRNAs converge on the transcription factor FOXP2 and promote breast cancer metastasis. (Cuiffo BG, Campagne A, Bell GW, Lembo A, Orso F, Lien EC, Bhasin MK, Raimo M, Hanson SE, Marusyk A, El-Ashry D, Hematti P, Polyak K, Mechta-Grigoriou F, Mariani O, Volinia S, Vincent-Salomon A, Taverna D, Karnoub AE) Cell Stem Cell 2014 Dec 04;15(6):762-74 PMID: 25515522 SCOPUS ID: 2-s2.0-84919442262 12/18/2014       148 Citations
  • Increasing incidence of chronic graft-versus-host disease in allogeneic transplantation: a report from the Center for International Blood and Marrow Transplant Research. (Arai S, Arora M, Wang T, Spellman SR, He W, Couriel DR, Urbano-Ispizua A, Cutler CS, Bacigalupo AA, Battiwalla M, Flowers ME, Juckett MB, Lee SJ, Loren AW, Klumpp TR, Prockup SE, Ringdén OT, Savani BN, Socié G, Schultz KR, Spitzer T, Teshima T, Bredeson CN, Jacobsohn DA, Hayashi RJ, Drobyski WR, Frangoul HA, Akpek G, Ho VT, Lewis VA, Gale RP, Koreth J, Chao NJ, Aljurf MD, Cooper BW, Laughlin MJ, Hsu JW, Hematti P, Verdonck LF, Solh MM, Norkin M, Reddy V, Martino R, Gadalla S, Goldberg JD, McCarthy PL, Pérez-Simón JA, Khera N, Lewis ID, Atsuta Y, Olsson RF, Saber W, Waller EK, Blaise D, Pidala JA, Martin PJ, Satwani P, Bornhäuser M, Inamoto Y, Weisdorf DJ, Horowitz MM, Pavletic SZ, Graft-vs-Host Disease Working Committee of the CIBMTR) Biol Blood Marrow Transplant 2015 Feb;21(2):266-74 PMID: 25445023 PMCID: PMC4326247 SCOPUS ID: 2-s2.0-84920903701 12/03/2014       308 Citations
  • A reproducible immunopotency assay to measure mesenchymal stromal cell-mediated T-cell suppression. (Bloom DD, Centanni JM, Bhatia N, Emler CA, Drier D, Leverson GE, McKenna DH Jr, Gee AP, Lindblad R, Hei DJ, Hematti P) Cytotherapy 2015 Feb;17(2):140-51 PMID: 25455739 PMCID: PMC4297551 SCOPUS ID: 2-s2.0-84922538007 12/03/2014       78 Citations
  • Race and ethnicity influences collection of granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells from unrelated donors, a Center for International Blood and Marrow Transplant Research analysis. (Hsu JW, Wingard JR, Logan BR, Chitphakdithai P, Akpek G, Anderlini P, Artz AS, Bredeson C, Goldstein S, Hale G, Hematti P, Joshi S, Kamble RT, Lazarus HM, O'Donnell PV, Pulsipher MA, Savani BN, Schears RM, Shaw BE, Confer DL) Biol Blood Marrow Transplant 2015 Jan;21(1):165-71 PMID: 25316111 PMCID: PMC4272878 SCOPUS ID: 2-s2.0-84927166294 10/16/2014       25 Citations
  • Cell therapy product administration and safety: data capture and analysis from the Production Assistance for Cellular Therapies (PACT) program. (Lindblad RW, Ibenana L, Wagner JE, McKenna DH Jr, Hei DJ, Hematti P, Couture LA, Silberstein LE, Armant M, Rooney CM, Gee AP, Welniak LA, Heath Mondoro T, Wood DA, Styers D) Transfusion 2015 Mar;55(3):674-9 PMID: 25315143 PMCID: PMC4357544 SCOPUS ID: 2-s2.0-84924386402 10/16/2014       5 Citations
  • Bilateral administration of autologous CD133+ cells in ambulatory patients with refractory critical limb ischemia: lessons learned from a pilot randomized, double-blind, placebo-controlled trial. (Raval AN, Schmuck EG, Tefera G, Leitzke C, Ark CV, Hei D, Centanni JM, de Silva R, Koch J, Chappell RG, Hematti P) Cytotherapy 2014 Dec;16(12):1720-32 PMID: 25239491 PMCID: PMC4253573 SCOPUS ID: 2-s2.0-84911911315 09/23/2014       40 Citations
  • Acetyl-L-carnitine (ALCAR) for the prevention of chemotherapy-induced peripheral neuropathy in patients with relapsed or refractory multiple myeloma treated with bortezomib, doxorubicin and low-dose dexamethasone: a study from the Wisconsin Oncology Network. (Callander N, Markovina S, Eickhoff J, Hutson P, Campbell T, Hematti P, Go R, Hegeman R, Longo W, Williams E, Asimakopoulos F, Miyamoto S) Cancer Chemother Pharmacol 2014 Oct;74(4):875-82 PMID: 25168296 PMCID: PMC4175433 SCOPUS ID: 2-s2.0-84919327424 08/30/2014       28 Citations
  • Biomaterial-mesenchymal stem cell constructs for immunomodulation in composite tissue engineering. (Hanson S, D'Souza RN, Hematti P) Tissue Eng Part A 2014 Aug;20(15-16):2162-8 PMID: 25140989 SCOPUS ID: 2-s2.0-84906538261 08/21/2014       59 Citations
  • Sleep quality following hematopoietic stem cell transplantation: longitudinal trajectories and biobehavioral correlates. (Nelson AM, Coe CL, Juckett MB, Rumble ME, Rathouz PJ, Hematti P, Costanzo ES) Bone Marrow Transplant 2014 Nov;49(11):1405-11 PMID: 25133898 PMCID: PMC4221490 SCOPUS ID: 2-s2.0-84909949200 08/19/2014       34 Citations
  • Influence of a dual-injection regimen, plerixafor and CXCR4 on in utero hematopoietic stem cell transplantation and engraftment with use of the sheep model. (Goodrich AD, Varain NM, Jeanblanc CM, Colon DM, Kim J, Zanjani ED, Hematti P) Cytotherapy 2014 Sep;16(9):1280-93 PMID: 25108653 PMCID: PMC4131210 SCOPUS ID: 2-s2.0-84905484443 08/12/2014       8 Citations
  • Mesenchymal stem cell therapies: the quest for fine-tuning. (Goodrich AD, Hematti P) Exp Dermatol 2014 Sep;23(9):632-3 PMID: 24806552 SCOPUS ID: 2-s2.0-84921896281 05/09/2014       6 Citations
  • Efficient manufacturing of therapeutic mesenchymal stromal cells with the use of the Quantum Cell Expansion System. (Hanley PJ, Mei Z, Durett AG, Cabreira-Hansen Mda G, Klis M, Li W, Zhao Y, Yang B, Parsha K, Mir O, Vahidy F, Bloom D, Rice RB, Hematti P, Savitz SI, Gee AP) Cytotherapy 2014 Aug;16(8):1048-58 PMID: 24726657 PMCID: PMC4087082 SCOPUS ID: 2-s2.0-84903814743 04/15/2014       119 Citations
  • TPL2 kinase regulates the inflammatory milieu of the myeloma niche. (Hope C, Ollar SJ, Heninger E, Hebron E, Jensen JL, Kim J, Maroulakou I, Miyamoto S, Leith C, Yang DT, Callander N, Hematti P, Chesi M, Bergsagel PL, Asimakopoulos F) Blood 2014 May 22;123(21):3305-15 PMID: 24723682 PMCID: PMC4046426 SCOPUS ID: 2-s2.0-84903177242 04/12/2014       79 Citations
  • Mesenchymal stem cells in hematopoietic stem cell transplantation (Hematti P, Kim J, Battiwalla M) Stem Cells and Human Diseases 1 April 2014:101-115 SCOPUS ID: 2-s2.0-84931454685 04/01/2014       2 Citations
  • An update from the United States National Heart, Lung, and Blood Institute-funded Production Assistance for Cellular Therapies (PACT) program: a decade of cell therapy. (Wood D, Wesselschmidt R, Hematti P, Gee AP, Rooney C, Silberstein L, Armant M, Couture L, Wagner JE, McKenna DH Jr, Hei D, Mondoro TH, Welniak L, Lindblad R) Clin Transl Sci 2014 Apr;7(2):93-9 PMID: 24655892 PMCID: PMC4006308 SCOPUS ID: 2-s2.0-84899624102 03/25/2014       7 Citations
  • Soliciting strategies for developing cell-based reference materials to advance mesenchymal stromal cell research and clinical translation. (Viswanathan S, Keating A, Deans R, Hematti P, Prockop D, Stroncek DF, Stacey G, Weiss DJ, Mason C, Rao MS) Stem Cells Dev 2014 Jun 01;23(11):1157-67 PMID: 24422625 PMCID: PMC4027980 SCOPUS ID: 2-s2.0-84901368359 01/16/2014       105 Citations
  • Harnessing regenerative and immunomodulatory properties of mesenchymal stem cells in transplantation medicine (Kim J, Hematti P) Regenerative Medicine Applications in Organ Transplantation 2014:163-175 SCOPUS ID: 2-s2.0-84902916870 01/01/2014       1 Citation
  • Comparison of breast and abdominal adipose tissue mesenchymal stromal/stem cells in support of proliferation of breast cancer cells. (Kim J, Escalante LE, Dollar BA, Hanson SE, Hematti P) Cancer Invest 2013 Oct;31(8):550-4 PMID: 24020962 PMCID: PMC4136465 SCOPUS ID: 2-s2.0-84885162919 09/12/2013       22 Citations
  • Comparative analysis of adipose-derived mesenchymal stem cells isolated from abdominal and breast tissue. (Hanson SE, Kim J, Hematti P) Aesthet Surg J 2013 Aug 01;33(6):888-98 PMID: 23908304 SCOPUS ID: 2-s2.0-84881169259 08/03/2013       29 Citations
  • No impact of lentiviral transduction on hematopoietic stem/progenitor cell telomere length or gene expression in the rhesus macaque model. (Sellers SE, Dumitriu B, Morgan MJ, Hughes WM, Wu CO, Raghavarchari N, Yang Y, Uchida N, Tisdale JF, An DS, Chen IS, Hematti P, Donahue RE, Larochelle A, Young NS, Calado RT, Dunbar CE) Mol Ther 2014 Jan;22(1):52-8 PMID: 23863881 PMCID: PMC3978805 SCOPUS ID: 2-s2.0-84891832674 07/19/2013       4 Citations
  • Thiol-ene Michael-type formation of gelatin/poly(ethylene glycol) biomatrices for three-dimensional mesenchymal stromal/stem cell administration to cutaneous wounds. (Xu K, Cantu DA, Fu Y, Kim J, Zheng X, Hematti P, Kao WJ) Acta Biomater 2013 Nov;9(11):8802-14 PMID: 23811217 PMCID: PMC3791182 SCOPUS ID: 2-s2.0-84885036993 07/03/2013       75 Citations
  • Mice engrafted with human fetal thymic tissue and hematopoietic stem cells develop pathology resembling chronic graft-versus-host disease. (Lockridge JL, Zhou Y, Becker YA, Ma S, Kenney SC, Hematti P, Capitini CM, Burlingham WJ, Gendron-Fitzpatrick A, Gumperz JE) Biol Blood Marrow Transplant 2013 Sep;19(9):1310-22 PMID: 23806772 PMCID: PMC3755109 SCOPUS ID: 2-s2.0-84882804581 06/29/2013       48 Citations
  • Generation of CD34+ cells from human embryonic stem cells using a clinically applicable methodology and engraftment in the fetal sheep model. (Kim J, Zanjani ED, Jeanblanc CM, Goodrich AD, Hematti P) Exp Hematol 2013 Aug;41(8):749-758.e5 PMID: 23612043 PMCID: PMC3729638 SCOPUS ID: 2-s2.0-84880746127 04/25/2013       8 Citations
  • In vitro characterization of macrophage interaction with mesenchymal stromal cell-hyaluronan hydrogel constructs. (King SN, Hanson SE, Chen X, Kim J, Hematti P, Thibeault SL) J Biomed Mater Res A 2014 Mar;102(3):890-902 PMID: 23564555 PMCID: PMC3849115 SCOPUS ID: 2-s2.0-84892581812 04/09/2013       35 Citations
  • Macrophages in multiple myeloma: emerging concepts and therapeutic implications. (Asimakopoulos F, Kim J, Denu RA, Hope C, Jensen JL, Ollar SJ, Hebron E, Flanagan C, Callander N, Hematti P) Leuk Lymphoma 2013 Oct;54(10):2112-21 PMID: 23432691 PMCID: PMC3686978 SCOPUS ID: 2-s2.0-84884493350 02/26/2013       46 Citations
  • Local delivery of allogeneic bone marrow and adipose tissue-derived mesenchymal stromal cells for cutaneous wound healing in a porcine model. (Hanson SE, Kleinbeck KR, Cantu D, Kim J, Bentz ML, Faucher LD, Kao WJ, Hematti P) J Tissue Eng Regen Med 2016 Feb;10(2):E90-E100 PMID: 23418160 PMCID: PMC4050123 SCOPUS ID: 2-s2.0-84957838812 02/19/2013       36 Citations
  • Brief report: Mesenchymal stromal cell atrophy in coculture increases aggressiveness of transformed cells. (Castellone MD, Laatikainen LE, Laurila JP, Langella A, Hematti P, Soricelli A, Salvatore M, Laukkanen MO) Stem Cells 2013 Jun;31(6):1218-23 PMID: 23404893 SCOPUS ID: 2-s2.0-84877990497 02/14/2013       23 Citations
  • Potential role of mesenchymal stromal cells in pancreatic islet transplantation. (Hematti P, Kim J, Stein AP, Kaufman D) Transplant Rev (Orlando) 2013 Jan;27(1):21-9 PMID: 23290684 SCOPUS ID: 2-s2.0-84873570068 01/08/2013       63 Citations
  • Mesenchymal stromal/stem cell transplantation: From tissue regeneration to immune modulation (Hematti P) Stem Cells Handbook: Second Edition 1 January 2013:391-397 SCOPUS ID: 2-s2.0-85028841272 01/01/2013       1 Citation
  • Mesenchymal stromal cells: Biology and clinical applications (Hematti P, Keating A) Mesenchymal Stromal Cells: Biology and Clinical Applications 1 January 2013:1-695 SCOPUS ID: 2-s2.0-85028505533 01/01/2013       9 Citations
  • Mesenchymal stromal cells in regenerative medicine: A perspective (Hematti P, Keating A) Mesenchymal Stromal Cells: Biology and Clinical Applications 1 January 2013:3-16 SCOPUS ID: 2-s2.0-84971462095 01/01/2013       8 Citations
  • MAP3K8 kinase regulates myeloma growth by cell-autonomous and non-autonomous mechanisms involving myeloma-associated monocytes/macrophages. (Hebron E, Hope C, Kim J, Jensen JL, Flanagan C, Bhatia N, Maroulakou I, Mitsiades C, Miyamoto S, Callander N, Hematti P, Asimakopoulos F) Br J Haematol 2013 Mar;160(6):779-84 PMID: 23252623 PMCID: PMC3594344 SCOPUS ID: 2-s2.0-84874705979 12/21/2012       10 Citations
  • Cell encapsulating biomaterial regulates mesenchymal stromal/stem cell differentiation and macrophage immunophenotype. (Cantu DA, Hematti P, Kao WJ) Stem Cells Transl Med 2012 Oct;1(10):740-9 PMID: 23197666 PMCID: PMC3659655 SCOPUS ID: 2-s2.0-84876511512 12/01/2012       44 Citations
  • Acute toxicities of unrelated bone marrow versus peripheral blood stem cell donation: results of a prospective trial from the National Marrow Donor Program. (Pulsipher MA, Chitphakdithai P, Logan BR, Shaw BE, Wingard JR, Lazarus HM, Waller EK, Seftel M, Stroncek DF, Lopez AM, Maharaj D, Hematti P, O'Donnell PV, Loren AW, Leitman SF, Anderlini P, Goldstein SC, Levine JE, Navarro WH, Miller JP, Confer DL) Blood 2013 Jan 03;121(1):197-206 PMID: 23109243 PMCID: PMC3538330 SCOPUS ID: 2-s2.0-84872059501 10/31/2012       101 Citations
  • Macrophages and mesenchymal stromal cells support survival and proliferation of multiple myeloma cells. (Kim J, Denu RA, Dollar BA, Escalante LE, Kuether JP, Callander NS, Asimakopoulos F, Hematti P) Br J Haematol 2012 Aug;158(3):336-46 PMID: 22583117 PMCID: PMC3395762 SCOPUS ID: 2-s2.0-84863812218 05/16/2012       99 Citations
  • Biologic and immunomodulatory properties of mesenchymal stromal cells derived from human pancreatic islets. (Kim J, Breunig MJ, Escalante LE, Bhatia N, Denu RA, Dollar BA, Stein AP, Hanson SE, Naderi N, Radek J, Haughy D, Bloom DD, Assadi-Porter FM, Hematti P) Cytotherapy 2012 Sep;14(8):925-35 PMID: 22571381 PMCID: PMC3537170 SCOPUS ID: 2-s2.0-84865762448 05/11/2012       25 Citations
  • Mesenchymal stromal cells and fibroblasts: a case of mistaken identity? (Hematti P) Cytotherapy 2012 May;14(5):516-21 PMID: 22458957 SCOPUS ID: 2-s2.0-84859777008 03/31/2012       132 Citations
  • HLA DR15 antigen status does not impact graft-versus-host disease or survival in HLA-matched sibling transplantation for hematologic malignancies. (Battiwalla M, Ellis K, Li P, Pavletic SZ, Akpek G, Hematti P, Klumpp TR, Maziarz RT, Savani BN, Aljurf MD, Cairo MS, Drobyski WR, George B, Hahn T, Khera N, Litzow MR, Loren AW, Saber W, Arora M, Urbano-Ispizua A, Cutler C, Flowers ME, Spellman SR) Biol Blood Marrow Transplant 2012 Aug;18(8):1302-8 PMID: 22414493 PMCID: PMC3580851 SCOPUS ID: 2-s2.0-84863996073 03/15/2012       10 Citations
  • Current applications of mesenchymal stem cells for tissue replacement in otolaryngology-head and neck surgery. (King SN, Hanson SE, Hematti P, Thibeault SL) Am J Stem Cells 2012;1(3):225-38 PMID: 23671810 PMCID: PMC3636735 01/01/2012    
  • Current applications of mesenchymal stem cells for tissue replacement in otolaryngology - head and neck surgery (King SN, Hanson SE, Hematti P, Thibeault SL) American Journal of Stem Cells 2012;1(3):225-238 SCOPUS ID: 2-s2.0-84995539275 01/01/2012       12 Citations
  • Human embryonic stem cell-derived mesenchymal stromal cells. (Hematti P) Transfusion 2011 Nov;51 Suppl 4(Suppl 4):138S-144S PMID: 22074624 PMCID: PMC3261503 SCOPUS ID: 2-s2.0-81055147537 12/07/2011       14 Citations
  • Erratum: Clinical operational tolerance after renal transplantation: Current status and future challenges (Annals of Surgery (2010) 252:6 (915-28)) (Orlando G, Hematti P, Stratta RJ) Annals of Surgery June 2011;253(6):1236 SCOPUS ID: 2-s2.0-79957524567 06/01/2011    
  • The effect of mesenchymal stromal cell-hyaluronic acid hydrogel constructs on immunophenotype of macrophages. (Hanson SE, King SN, Kim J, Chen X, Thibeault SL, Hematti P) Tissue Eng Part A 2011 Oct;17(19-20):2463-71 PMID: 21554192 PMCID: PMC3179618 SCOPUS ID: 2-s2.0-80053121333 05/11/2011       49 Citations
  • Clinical applications of mesenchymal stem cells in soft tissue augmentation. (Hanson SE, Gutowski KA, Hematti P) Aesthet Surg J 2010;30(6):838-42 PMID: 21131458 PMCID: PMC4074905 SCOPUS ID: 2-s2.0-78650832351 12/07/2010       43 Citations
  • Mesenchymal stromal cells are present in the heart and promote growth of adult stem cells in vitro. (Lushaj EB, Anstadt E, Haworth R, Roenneburg D, Kim J, Hematti P, Kohmoto T) Cytotherapy 2011 Apr;13(4):400-6 PMID: 21090918 SCOPUS ID: 2-s2.0-79952667750 11/26/2010       22 Citations
  • Clinical operational tolerance after renal transplantation: current status and future challenges. (Orlando G, Hematti P, Stratta RJ, Burke GW 3rd, Di Cocco P, Pisani F, Soker S, Wood K) Ann Surg 2010 Dec;252(6):915-28 PMID: 21107102 PMCID: PMC4547843 SCOPUS ID: 2-s2.0-78650179150 11/26/2010       109 Citations
  • Human embryonic stem cell-derived mesenchymal progenitors: an overview. (Hematti P) Methods Mol Biol 2011;690:163-74 PMID: 21042992 SCOPUS ID: 2-s2.0-78650057056 11/03/2010       37 Citations
  • Graft-versus-host disease: role of inflammation in the development of chromosomal abnormalities of keratinocytes. (Sloand EM, Pfannes L, Ling C, Feng X, Jasek M, Calado R, Tucker ZC, Hematti P, Maciejewski J, Dunbar C, Barrett J, Young N) Biol Blood Marrow Transplant 2010 Dec;16(12):1665-73 PMID: 20659573 PMCID: PMC3437935 SCOPUS ID: 2-s2.0-78149410631 07/28/2010       19 Citations
  • Bone marrow stromal cells from multiple myeloma patients uniquely induce bortezomib resistant NF-kappaB activity in myeloma cells. (Markovina S, Callander NS, O'Connor SL, Xu G, Shi Y, Leith CP, Kim K, Trivedi P, Kim J, Hematti P, Miyamoto S) Mol Cancer 2010 Jul 06;9:176 PMID: 20604947 PMCID: PMC3095250 SCOPUS ID: 2-s2.0-77954194855 07/08/2010       96 Citations
  • Characterization of mesenchymal stem cells from human vocal fold fibroblasts. (Hanson SE, Kim J, Johnson BH, Bradley B, Breunig MJ, Hematti P, Thibeault SL) Laryngoscope 2010 Mar;120(3):546-51 PMID: 20131365 PMCID: PMC2829335 SCOPUS ID: 2-s2.0-77949538076 02/05/2010       63 Citations
  • Mesenchymal stem cell therapy for nonhealing cutaneous wounds. (Hanson SE, Bentz ML, Hematti P) Plast Reconstr Surg 2010 Feb;125(2):510-516 PMID: 20124836 PMCID: PMC4076140 SCOPUS ID: 2-s2.0-76949083500 02/04/2010       131 Citations
  • Clinical applications of mesenchymal stem cells in laryngotracheal reconstruction. (Hanson S, Thibeault SL, Hematti P) Curr Stem Cell Res Ther 2010 Sep;5(3):268-72 PMID: 19951250 PMCID: PMC3167577 SCOPUS ID: 2-s2.0-77957667005 12/03/2009       15 Citations
  • Human embryonic stem cell-derived mesenchymal stromal cell transplantation in a rat hind limb injury model. (Laurila JP, Laatikainen L, Castellone MD, Trivedi P, Heikkila J, Hinkkanen A, Hematti P, Laukkanen MO) Cytotherapy 2009;11(6):726-37 PMID: 19878059 PMCID: PMC2889035 SCOPUS ID: 2-s2.0-73649115624 11/03/2009       59 Citations
  • Generation of mesenchymal stromal cells from HOXB4-expressing human embryonic stem cells. (Liu YP, Hematti P) Cytotherapy 2009;11(6):716-25 PMID: 19878058 PMCID: PMC2774218 SCOPUS ID: 2-s2.0-73649138531 11/03/2009       7 Citations
  • Mesenchymal stem cell-educated macrophages: a novel type of alternatively activated macrophages. (Kim J, Hematti P) Exp Hematol 2009 Dec;37(12):1445-53 PMID: 19772890 PMCID: PMC2783735 SCOPUS ID: 2-s2.0-70449527554 09/24/2009       650 Citations
  • Mesenchymal stem cells in hematopoietic stem cell transplantation. (Battiwalla M, Hematti P) Cytotherapy 2009;11(5):503-15 PMID: 19728189 PMCID: PMC2766085 SCOPUS ID: 2-s2.0-70849132807 09/04/2009       161 Citations
  • Sustained high-level polyclonal hematopoietic marking and transgene expression 4 years after autologous transplantation of rhesus macaques with SIV lentiviral vector-transduced CD34+ cells. (Kim YJ, Kim YS, Larochelle A, Renaud G, Wolfsberg TG, Adler R, Donahue RE, Hematti P, Hong BK, Roayaei J, Akagi K, Riberdy JM, Nienhuis AW, Dunbar CE, Persons DA) Blood 2009 May 28;113(22):5434-43 PMID: 19339698 PMCID: PMC2689045 SCOPUS ID: 2-s2.0-67049137374 04/03/2009       41 Citations
  • Role of mesenchymal stromal cells in solid organ transplantation. (Hematti P) Transplant Rev (Orlando) 2008 Oct;22(4):262-73 PMID: 18656340 PMCID: PMC2576746 SCOPUS ID: 2-s2.0-51749091067 07/29/2008       75 Citations
  • Derivation and immunological characterization of mesenchymal stromal cells from human embryonic stem cells. (Trivedi P, Hematti P) Exp Hematol 2008 Mar;36(3):350-9 PMID: 18179856 PMCID: PMC2315792 SCOPUS ID: 2-s2.0-39149141866 01/09/2008       155 Citations
  • Simultaneous generation of CD34+ primitive hematopoietic cells and CD73+ mesenchymal stem cells from human embryonic stem cells cocultured with murine OP9 stromal cells. (Trivedi P, Hematti P) Exp Hematol 2007 Jan;35(1):146-54 PMID: 17198883 SCOPUS ID: 2-s2.0-33845732729 01/03/2007       65 Citations
  • AMD3100 mobilizes hematopoietic stem cells with long-term repopulating capacity in nonhuman primates. (Larochelle A, Krouse A, Metzger M, Orlic D, Donahue RE, Fricker S, Bridger G, Dunbar CE, Hematti P) Blood 2006 May 01;107(9):3772-8 PMID: 16439684 PMCID: PMC1895780 SCOPUS ID: 2-s2.0-33646398840 01/28/2006       173 Citations
  • Nonhuman primate embryonic stem cells as a preclinical model for hematopoietic and vascular repair. (Hematti P, Obrtlikova P, Kaufman DS) Exp Hematol 2005 Sep;33(9):980-6 PMID: 16140145 SCOPUS ID: 2-s2.0-24044474697 09/06/2005       20 Citations
  • Recurrent retroviral vector integration at the Mds1/Evi1 locus in nonhuman primate hematopoietic cells. (Calmels B, Ferguson C, Laukkanen MO, Adler R, Faulhaber M, Kim HJ, Sellers S, Hematti P, Schmidt M, von Kalle C, Akagi K, Donahue RE, Dunbar CE) Blood 2005 Oct 01;106(7):2530-3 PMID: 15933056 PMCID: PMC1895268 SCOPUS ID: 2-s2.0-25144490586 06/04/2005       136 Citations
  • Distinct genomic integration of MLV and SIV vectors in primate hematopoietic stem and progenitor cells. (Hematti P, Hong BK, Ferguson C, Adler R, Hanawa H, Sellers S, Holt IE, Eckfeldt CE, Sharma Y, Schmidt M, von Kalle C, Persons DA, Billings EM, Verfaillie CM, Nienhuis AW, Wolfsberg TG, Dunbar CE, Calmels B) PLoS Biol 2004 Dec;2(12):e423 PMID: 15550989 PMCID: PMC529319 SCOPUS ID: 2-s2.0-20044396722 11/20/2004       231 Citations
  • Comparison of retroviral transduction efficiency in CD34+ cells derived from bone marrow versus G-CSF-mobilized or G-CSF plus stem cell factor-mobilized peripheral blood in nonhuman primates. (Hematti P, Tuchman S, Larochelle A, Metzger ME, Donahue RE, Tisdale JF) Stem Cells 2004;22(6):1062-9 PMID: 15536196 SCOPUS ID: 2-s2.0-8644291701 11/13/2004       18 Citations
  • Modeling human hematopoietic stem cell gene therapy in nonhuman primates. (Hematti P) Curr Hematol Rep 2004 Jul;3(4):282-9 PMID: 15217558 SCOPUS ID: 2-s2.0-4644283155 06/26/2004       4 Citations
  • The impact of low-dose busulfan on clonal dynamics in nonhuman primates. (Kuramoto K, Follman D, Hematti P, Sellers S, Laukkanen MO, Seggewiss R, Metzger ME, Krouse A, Donahue RE, von Kalle C, Dunbar CE) Blood 2004 Sep 01;104(5):1273-80 PMID: 15126320 SCOPUS ID: 2-s2.0-4444302256 05/06/2004       34 Citations
  • Long-term clinical and molecular follow-up of large animals receiving retrovirally transduced stem and progenitor cells: no progression to clonal hematopoiesis or leukemia. (Kiem HP, Sellers S, Thomasson B, Morris JC, Tisdale JF, Horn PA, Hematti P, Adler R, Kuramoto K, Calmels B, Bonifacino A, Hu J, von Kalle C, Schmidt M, Sorrentino B, Nienhuis A, Blau CA, Andrews RG, Donahue RE, Dunbar CE) Mol Ther 2004 Mar;9(3):389-95 PMID: 15006605 SCOPUS ID: 2-s2.0-12144289202 03/10/2004       85 Citations
  • Efficient gene transfer into rhesus repopulating hematopoietic stem cells using a simian immunodeficiency virus-based lentiviral vector system. (Hanawa H, Hematti P, Keyvanfar K, Metzger ME, Krouse A, Donahue RE, Kepes S, Gray J, Dunbar CE, Persons DA, Nienhuis AW) Blood 2004 Jun 01;103(11):4062-9 PMID: 14976042 SCOPUS ID: 2-s2.0-2542501560 02/21/2004       154 Citations
  • Effect of chronic cytokine therapy on clonal dynamics in nonhuman primates. (Kuramoto K, Follmann DA, Hematti P, Sellers S, Agricola BA, Metzger ME, Donahue RE, von Kalle C, Dunbar CE) Blood 2004 Jun 01;103(11):4070-7 PMID: 14962906 SCOPUS ID: 2-s2.0-2542452856 02/14/2004       14 Citations
  • Retroviral transduction efficiency of G-CSF+SCF-mobilized peripheral blood CD34+ cells is superior to G-CSF or G-CSF+Flt3-L-mobilized cells in nonhuman primates. (Hematti P, Sellers SE, Agricola BA, Metzger ME, Donahue RE, Dunbar CE) Blood 2003 Mar 15;101(6):2199-205 PMID: 12424191 SCOPUS ID: 2-s2.0-0037443484 11/09/2002       46 Citations
  • Absence of donor-derived keratinocyte stem cells in skin tissues cultured from patients after mobilized peripheral blood hematopoietic stem cell transplantation. (Hematti P, Sloand EM, Carvallo CA, Albert MR, Yee CL, Fuehrer MM, Blancato JK, Kearns WG, Barrett JA, Childs RW, Vogel JC, Dunbar CE) Exp Hematol 2002 Aug;30(8):943-9 PMID: 12160846 SCOPUS ID: 2-s2.0-18444400844 08/06/2002       41 Citations
  • Genetic marking as an approach to studying in vivo hematopoiesis: progress in the non-human primate model. (Shi PA, Hematti P, von Kalle C, Dunbar CE) Oncogene 2002 May 13;21(21):3274-83 PMID: 12032769 SCOPUS ID: 2-s2.0-0037071417 05/29/2002       27 Citations
  • Presumed choroidal and orbital mastocytosis. (Fine HF, Akin C, Hematti P, Butman J, Caruso RC, Csaky KG, Metcalfe DD, Nussenblatt RB, Robinson MR) Arch Ophthalmol 2001 Nov;119(11):1716-9 PMID: 11709028 SCOPUS ID: 2-s2.0-0034767271 11/16/2001       11 Citations
    • Last update: 04/23/2024